Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   gastric cancer
  

Disease ID 639
Disease gastric cancer
Definition
A primary or metastatic malignant neoplasm involving the stomach.
Synonym
#NAME?
ca - cancer of stomach
ca stomach nos
ca stomach nos (disorder)
cancer of stomach
cancer of the stomach
cancer, gastric
cancer, stomach
cancers, gastric
cancers, stomach
gastric cancers
malig neopl stomach nos
malignant gastric neoplasm
malignant gastric tumor
malignant neoplasm of stomach
malignant neoplasm of stomach nos
malignant neoplasm of stomach nos (disorder)
malignant neoplasm of stomach, nos
malignant neoplasm of stomach, unspecified
malignant neoplasm of stomach, unspecified site
malignant neoplasm of the stomach
malignant neoplasm stomach
malignant tumor of stomach
malignant tumor of stomach (disorder)
malignant tumor of the stomach
malignant tumour of stomach
malignant tumour of stomach (disorder)
stomach ca
stomach cancer
stomach cancers
stomach--cancer
OMIM
DOID
ICD10
UMLS
C0024623
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:223)
C0494165  |  liver metastasis  |  49
C0494165  |  liver metastases  |  37
C0686619  |  lymph node metastases  |  29
C0948303  |  peritoneal carcinoma  |  26
C0017152  |  gastritis  |  23
C0001173  |  gastric outlet obstruction  |  13
C0030920  |  peptic ulcer  |  11
C0001418  |  adenocarcinoma  |  10
C0007113  |  rectal cancer  |  9
C0011847  |  diabetes  |  9
C0011860  |  type 2 diabetes  |  9
C0017154  |  atrophic gastritis  |  9
C0009402  |  colorectal cancer  |  8
C0494165  |  hepatic metastases  |  8
C0034194  |  pyloric stenosis  |  6
C0006625  |  cachexia  |  6
C0242379  |  lung cancer  |  6
C0012739  |  disseminated intravascular coagulation  |  6
C0024225  |  lymphangitis  |  5
C0030920  |  peptic ulcer disease  |  5
C0014859  |  esophageal cancer  |  5
C0024299  |  lymphoma  |  5
C0220650  |  brain metastasis  |  4
C0002871  |  anemia  |  4
C0020538  |  hypertension  |  4
C0011849  |  diabetes mellitus  |  4
C0494165  |  hepatic metastasis  |  4
C0006142  |  breast cancer  |  4
C0013295  |  duodenal ulcer  |  4
C0007134  |  renal cell carcinoma  |  4
C0007102  |  colon cancer  |  4
C0031154  |  peritonitis  |  4
C0036202  |  sarcoidosis  |  3
C1333990  |  lynch syndrome  |  3
C0021843  |  intestinal obstruction  |  3
C0040053  |  thrombosis  |  3
C0349530  |  early gastric cancer  |  3
C0013395  |  dyspepsia  |  3
C0278701  |  gastric adenocarcinoma  |  3
C0022354  |  obstructive jaundice  |  3
C0023890  |  cirrhosis  |  3
C0028754  |  obesity  |  3
C0282207  |  cronkhite-canada syndrome  |  3
C0023890  |  liver cirrhosis  |  3
C0155765  |  microangiopathy  |  3
C0242363  |  islet cell tumor  |  3
C0153676  |  lung metastasis  |  3
C0040053  |  thrombus  |  3
C0024623  |  gastric cancers  |  3
C0699791  |  gastric carcinoma  |  3
C0020541  |  portal hypertension  |  3
C1541124  |  pyloric obstruction  |  3
C0152018  |  esophageal carcinoma  |  2
C0948265  |  metabolic syndrome  |  2
C0022658  |  kidney disease  |  2
C0235974  |  pancreatic cancer  |  2
C0032580  |  familial adenomatous polyposis  |  2
C0007137  |  squamous cell carcinoma  |  2
C0022661  |  chronic kidney disease  |  2
C0006625  |  cachectic  |  2
C0042847  |  vitamin b12 defic  |  2
C0001727  |  afferent loop syndrome  |  2
C0220650  |  brain metastases  |  2
C0026986  |  myelodysplastic syndrome  |  2
C0008497  |  choriocarcinoma  |  2
C0012739  |  disseminated intravascular coagulation (dic)  |  2
C0079419  |  li-fraumeni syndrome  |  2
C0034885  |  rectal neoplasms  |  2
C0080032  |  malignant effusion  |  2
C0334277  |  metastatic adenocarcinoma  |  2
C0042769  |  virus infection  |  2
C0007133  |  papillary carcinoma  |  2
C0026636  |  oral disease  |  2
C0001418  |  adenocarcinomas  |  2
C0879615  |  stromal tumor  |  2
C0001430  |  adenoma  |  2
C0030920  |  peptic ulcers  |  2
C0153676  |  pulmonary metastasis  |  2
C0376358  |  prostate cancer  |  2
C0001125  |  lactic acidosis  |  2
C0011570  |  depression  |  2
C0038358  |  gastric ulcer  |  2
C0017154  |  chronic atrophic gastritis  |  2
C0042847  |  vitamin b12 deficiency  |  2
C0029456  |  osteoporosis  |  2
C0238198  |  gastrointestinal stromal tumor  |  2
C0035078  |  renal failure  |  2
C0042384  |  vasculitis  |  2
C0021843  |  bowel obstruction  |  2
C0043121  |  wernicke encephalopathy  |  1
C0032580  |  adenomatous polyposis  |  1
C0011860  |  type 2 diabetes mellitus  |  1
C0017155  |  menetrier's disease  |  1
C0009319  |  colitis  |  1
C0003615  |  appendicitis  |  1
C0008350  |  gallstone  |  1
C0023903  |  liver tumor  |  1
C1704214  |  xanthogranuloma  |  1
C0235250  |  hyperemesis  |  1
C0014868  |  esophagitis  |  1
C0023895  |  liver disease  |  1
C0032285  |  pneumonia  |  1
C0023434  |  chronic lymphocytic leukemia  |  1
C0236642  |  pick disease  |  1
C0003467  |  anxiety  |  1
C0001175  |  acquired immunodeficiency syndrome (aids)  |  1
C0002874  |  aplastic anemia  |  1
C0279628  |  oesophageal adenocarcinoma  |  1
C0038358  |  gastric ulcers  |  1
C0031269  |  peutz-jeghers syndrome  |  1
C0036202  |  sarcoid  |  1
C1262481  |  eosinophilic gastroenteritis  |  1
C0242379  |  lung cancers  |  1
C0014848  |  achalasia  |  1
C0685938  |  gi cancer  |  1
C0022661  |  end-stage renal disease  |  1
C0041296  |  tuberculosis  |  1
C0032463  |  polycythemia vera  |  1
C0002892  |  pernicious anemia  |  1
C0020701  |  hysteria  |  1
C0392525  |  nephrolithiasis  |  1
C0685938  |  gastrointestinal cancer  |  1
C0155773  |  portal vein thrombosis  |  1
C0020450  |  hyperemesis gravidarum  |  1
C0409974  |  lupus erythematosus  |  1
C0007115  |  thyroid ca  |  1
C1140680  |  ovarian cancer  |  1
C0007642  |  cellulitis  |  1
C0346627  |  intestinal cancers  |  1
C0014869  |  reflux esophagitis  |  1
C0854178  |  adrenal metastases  |  1
C0009447  |  common variable immunodeficiency  |  1
C0014145  |  yolk sac tumor  |  1
C0027830  |  neurofibroma  |  1
C0042373  |  vascular disease  |  1
C0178879  |  obstructive uropathy  |  1
C0038362  |  stomatitis  |  1
C0009324  |  ulcerative colitis  |  1
C0007137  |  squamous carcinoma  |  1
C0007222  |  cardiovascular disease  |  1
C0279628  |  esophageal adenocarcinoma  |  1
C0238198  |  gastrointestinal stromal tumor (gist)  |  1
C0020295  |  hydronephrosis  |  1
C0279626  |  squamous cell carcinoma of the esophagus  |  1
C0017154  |  gastric atrophy  |  1
C0024117  |  chronic obstructive pulmonary disease  |  1
C0151436  |  leucocytoclastic vasculitis  |  1
C0042075  |  uropathy  |  1
C0685938  |  digestive cancer  |  1
C1527249  |  colorectal cancers  |  1
C0037293  |  fibroepithelial polyp  |  1
C0024623  |  stomach cancer  |  1
C1704231  |  leptomeningeal metastasis  |  1
C0028064  |  niemann-pick disease  |  1
C0162316  |  iron deficiency anemia  |  1
C0153452  |  gallbladder cancer  |  1
C0242647  |  mucosa-associated lymphoid tissue lymphoma  |  1
C0153452  |  gallbladder ca  |  1
C0549473  |  thyroid carcinoma  |  1
C0005940  |  bone disease  |  1
C0278701  |  adenocarcinoma of the stomach  |  1
C0442874  |  neuropathy  |  1
C0003949  |  asbestosis  |  1
C0699791  |  carcinoma of the stomach  |  1
C0040034  |  thrombocytopenia  |  1
C0022661  |  chronic renal failure  |  1
C0024301  |  follicular lymphoma  |  1
C0011633  |  dermatomyositis  |  1
C0017160  |  gastroenteritis  |  1
C0018418  |  gynecomastia  |  1
C0001175  |  acquired immunodeficiency syndrome  |  1
C0024141  |  systemic lupus erythematosus  |  1
C0027947  |  neutropenia  |  1
C0349532  |  gastric lymphoma  |  1
C0042961  |  volvulus  |  1
C0159069  |  impaired glucose tolerance  |  1
C0018801  |  heart failure  |  1
C0023267  |  fibroid  |  1
C0345893  |  juvenile polyposis  |  1
C0008370  |  bile duct obstruction  |  1
C1140680  |  ovarian ca  |  1
C0024115  |  pulmonary disease  |  1
C0007177  |  cardiac tamponade  |  1
C0013295  |  duodenal ulcers  |  1
C0024299  |  malignant lymphoma  |  1
C0023448  |  lymphocytic leukemia  |  1
C0238463  |  papillary thyroid carcinoma  |  1
C0011334  |  cavities  |  1
C0032461  |  polycythemia  |  1
C0020532  |  hypersplenism  |  1
C0162429  |  malnourished  |  1
C0031039  |  pericardial effusion  |  1
C0037274  |  dermatoses  |  1
C0033860  |  psoriasis  |  1
C0023976  |  long qt syndrome  |  1
C0038358  |  gastric ulceration  |  1
C0023743  |  linitis plastica  |  1
C0014118  |  endocarditis  |  1
C0022658  |  renal disease  |  1
C0345893  |  juvenile polyposis syndrome  |  1
C0600260  |  obstructive pulmonary disease  |  1
C0020598  |  hypoglycemia  |  1
C0302592  |  cervical ca  |  1
C0685938  |  gastrointestinal cancers  |  1
C0002766  |  analgesia  |  1
C0005684  |  bladder cancer  |  1
C0153676  |  lung metastases  |  1
C0008350  |  cholelithiasis  |  1
C0023418  |  leukemia  |  1
C0546837  |  esophageal cancers  |  1
C0042133  |  uterine fibroid  |  1
C0153676  |  pulmonary metastases  |  1
C0026934  |  mycoplasma  |  1
C0334254  |  lymphoepithelioma  |  1
C0022116  |  ischemia  |  1
C0699790  |  colon carcinoma  |  1
C0008325  |  cholecystitis  |  1
C0031046  |  pericarditis  |  1
C0162429  |  malnutrition  |  1
C0153687  |  skin metastasis  |  1
C0206623  |  adenosquamous carcinoma  |  1
C0007847  |  cervical cancer  |  1
C0034186  |  pyelonephritis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:5)
MUC1  |  4582  |  GWASCAT
CHEK2  |  11200  |  GWASCAT
PRKAA1  |  5562  |  GWASCAT
ZBTB20  |  26137  |  GWASCAT
PLCE1  |  51196  |  GWASCAT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:108)
5243  |  ABCB1  |  infer
472  |  ATM  |  infer
6790  |  AURKA  |  infer
999  |  CDH1  |  infer
1493  |  CTLA4  |  infer
1543  |  CYP1A1  |  infer
1548  |  CYP2A6  |  infer
1571  |  CYP2E1  |  infer
1789  |  DNMT3B  |  infer
1956  |  EGFR  |  infer
2064  |  ERBB2  |  infer
2067  |  ERCC1  |  infer
2068  |  ERCC2  |  infer
2212  |  FCGR2A  |  infer
2214  |  FCGR3A  |  infer
2778  |  GNAS  |  infer
2944  |  GSTM1  |  infer
2947  |  GSTM3  |  infer
2950  |  GSTP1  |  infer
2952  |  GSTT1  |  infer
3303  |  HSPA1A  |  infer
3304  |  HSPA1B  |  infer
3305  |  HSPA1L  |  infer
3586  |  IL10  |  infer
3605  |  IL17A  |  infer
112744  |  IL17F  |  infer
3553  |  IL1B  |  infer
3557  |  IL1RN  |  infer
3845  |  KRAS  |  infer
4049  |  LTA  |  infer
406973  |  MIR196A2  |  infer
4292  |  MLH1  |  infer
4436  |  MSH2  |  infer
2956  |  MSH6  |  infer
4524  |  MTHFR  |  infer
4968  |  OGG1  |  infer
5225  |  PGC  |  infer
5790  |  PTPRCAP  |  infer
7039  |  TGFA  |  infer
7048  |  TGFBR2  |  infer
7124  |  TNF  |  infer
7157  |  TP53  |  infer
7298  |  TYMS  |  infer
54577  |  UGT1A7  |  infer
7517  |  XRCC3  |  infer
7518  |  XRCC4  |  infer
1636  |  ACE  |  infer
186  |  AGTR2  |  infer
217  |  ALDH2  |  infer
324  |  APC  |  infer
8945  |  BTRC  |  infer
595  |  CCND1  |  infer
929  |  CD14  |  infer
1026  |  CDKN1A  |  infer
1029  |  CDKN2A  |  infer
1499  |  CTNNB1  |  infer
1544  |  CYP1A2  |  infer
1557  |  CYP2C19  |  infer
1950  |  EGF  |  infer
2052  |  EPHX1  |  infer
355  |  FAS  |  infer
2346  |  FOLH1  |  infer
2348  |  FOLR1  |  infer
2932  |  GSK3B  |  infer
2957  |  GTF2A1  |  infer
3117  |  HLA-DQA1  |  infer
3119  |  HLA-DQB1  |  infer
3123  |  HLA-DRB1  |  infer
3458  |  IFNG  |  infer
3460  |  IFNGR2  |  infer
3592  |  IL12A  |  infer
3606  |  IL18  |  infer
3552  |  IL1A  |  infer
3558  |  IL2  |  infer
3565  |  IL4  |  infer
3566  |  IL4R  |  infer
3569  |  IL6  |  infer
3815  |  KIT  |  infer
43849  |  KLK12  |  infer
55353  |  LAPTM4B  |  infer
4193  |  MDM2  |  infer
4255  |  MGMT  |  infer
4312  |  MMP1  |  infer
4313  |  MMP2  |  infer
4318  |  MMP9  |  infer
4353  |  MPO  |  infer
4522  |  MTHFD1  |  infer
4548  |  MTR  |  infer
4549  |  MT-RNR1  |  infer
4552  |  MTRR  |  infer
4609  |  MYC  |  infer
4619  |  MYH1  |  infer
10  |  NAT2  |  infer
4683  |  NBN  |  infer
143  |  PARP4  |  infer
5156  |  PDGFRA  |  infer
5743  |  PTGS2  |  infer
5888  |  RAD51  |  infer
6573  |  SLC19A1  |  infer
6648  |  SOD2  |  infer
6817  |  SULT1A1  |  infer
7040  |  TGFB1  |  infer
7077  |  TIMP2  |  infer
7099  |  TLR4  |  infer
8797  |  TNFRSF10A  |  infer
7159  |  TP53BP2  |  infer
7422  |  VEGFA  |  infer
7515  |  XRCC1  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:699)
100507056  |  CCAT1  |  DISEASES
1087  |  CEACAM7  |  DISEASES
4830  |  NME1  |  DISEASES
2067  |  ERCC1  |  DISEASES
6591  |  SNAI2  |  DISEASES
1015  |  CDH17  |  DISEASES
634  |  CEACAM1  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
54474  |  KRT20  |  DISEASES
2249  |  FGF4  |  DISEASES
7145  |  TNS1  |  DISEASES
51208  |  CLDN18  |  DISEASES
27248  |  ERLEC1  |  DISEASES
64090  |  GAL3ST2  |  DISEASES
27292  |  DIMT1  |  DISEASES
4680  |  CEACAM6  |  DISEASES
6820  |  SULT2B1  |  DISEASES
28954  |  REM1  |  DISEASES
2734  |  GLG1  |  DISEASES
2099  |  ESR1  |  DISEASES
23411  |  SIRT1  |  DISEASES
4320  |  MMP11  |  DISEASES
5594  |  MAPK1  |  DISEASES
23492  |  CBX7  |  DISEASES
1113  |  CHGA  |  DISEASES
4792  |  NFKBIA  |  DISEASES
5721  |  PSME2  |  DISEASES
57167  |  SALL4  |  DISEASES
79444  |  BIRC7  |  DISEASES
1917  |  EEF1A2  |  DISEASES
113278  |  SLC52A3  |  DISEASES
9352  |  TXNL1  |  DISEASES
10857  |  PGRMC1  |  DISEASES
7076  |  TIMP1  |  DISEASES
479  |  ATP12A  |  DISEASES
4313  |  MMP2  |  DISEASES
64714  |  PDIA2  |  DISEASES
9100  |  USP10  |  DISEASES
1891  |  ECH1  |  DISEASES
79187  |  FSD1  |  DISEASES
7040  |  TGFB1  |  DISEASES
973  |  CD79A  |  DISEASES
1048  |  CEACAM5  |  DISEASES
2057  |  EPOR  |  DISEASES
6142  |  RPL18A  |  DISEASES
3082  |  HGF  |  DISEASES
7980  |  TFPI2  |  DISEASES
10392  |  NOD1  |  DISEASES
11333  |  PDAP1  |  DISEASES
1440  |  CSF3  |  DISEASES
6198  |  RPS6KB1  |  DISEASES
3558  |  IL2  |  DISEASES
3732  |  CD82  |  DISEASES
595  |  CCND1  |  DISEASES
2735  |  GLI1  |  DISEASES
1027  |  CDKN1B  |  DISEASES
3458  |  IFNG  |  DISEASES
2597  |  GAPDH  |  DISEASES
2026  |  ENO2  |  DISEASES
79923  |  NANOG  |  DISEASES
57379  |  AICDA  |  DISEASES
11021  |  RAB35  |  DISEASES
1839  |  HBEGF  |  DISEASES
6678  |  SPARC  |  DISEASES
3565  |  IL4  |  DISEASES
1044  |  CDX1  |  DISEASES
4292  |  MLH1  |  DISEASES
604  |  BCL6  |  DISEASES
7372  |  UMPS  |  DISEASES
4436  |  MSH2  |  DISEASES
4759  |  NEU2  |  DISEASES
4953  |  ODC1  |  DISEASES
2956  |  MSH6  |  DISEASES
2023  |  ENO1  |  DISEASES
9528  |  TMEM59  |  DISEASES
1509  |  CTSD  |  DISEASES
51146  |  A4GNT  |  DISEASES
1933  |  EEF1B2  |  DISEASES
7276  |  TTR  |  DISEASES
7374  |  UNG  |  DISEASES
79586  |  CHPF  |  DISEASES
5335  |  PLCG1  |  DISEASES
6615  |  SNAI1  |  DISEASES
222643  |  UNC5CL  |  DISEASES
1026  |  CDKN1A  |  DISEASES
9271  |  PIWIL1  |  DISEASES
83596  |  BCL2L12  |  DISEASES
1773  |  DNASE1  |  DISEASES
6495  |  SIX1  |  DISEASES
30848  |  CTAG2  |  DISEASES
3315  |  HSPB1  |  DISEASES
23544  |  SEZ6L  |  DISEASES
2952  |  GSTT1  |  DISEASES
53947  |  A4GALT  |  DISEASES
22933  |  SIRT2  |  DISEASES
968  |  CD68  |  DISEASES
3630  |  INS  |  DISEASES
56986  |  DTWD1  |  DISEASES
1890  |  TYMP  |  DISEASES
23113  |  CUL9  |  DISEASES
341  |  APOC1  |  DISEASES
25796  |  PGLS  |  DISEASES
9518  |  GDF15  |  DISEASES
1571  |  CYP2E1  |  DISEASES
78992  |  YIPF2  |  DISEASES
84660  |  CCDC62  |  DISEASES
9476  |  NAPSA  |  DISEASES
84152  |  PPP1R1B  |  DISEASES
3958  |  LGALS3  |  DISEASES
6382  |  SDC1  |  DISEASES
23647  |  ARFIP2  |  DISEASES
1401  |  CRP  |  DISEASES
29958  |  DMGDH  |  DISEASES
28992  |  MACROD1  |  DISEASES
3845  |  KRAS  |  DISEASES
10894  |  LYVE1  |  DISEASES
8748  |  ADAM20  |  DISEASES
27299  |  ADAMDEC1  |  DISEASES
891  |  CCNB1  |  DISEASES
1022  |  CDK7  |  DISEASES
83998  |  REG4  |  DISEASES
2694  |  GIF  |  DISEASES
301  |  ANXA1  |  DISEASES
3569  |  IL6  |  DISEASES
11227  |  GALNT5  |  DISEASES
3557  |  IL1RN  |  DISEASES
29113  |  C6orf15  |  DISEASES
7097  |  TLR2  |  DISEASES
4316  |  MMP7  |  DISEASES
7057  |  THBS1  |  DISEASES
26160  |  IFT172  |  DISEASES
51196  |  PLCE1  |  DISEASES
2984  |  GUCY2C  |  DISEASES
4069  |  LYZ  |  DISEASES
5037  |  PEBP1  |  DISEASES
5687  |  PSMA6  |  DISEASES
23326  |  USP22  |  DISEASES
51283  |  BFAR  |  DISEASES
57551  |  TAOK1  |  DISEASES
217  |  ALDH2  |  DISEASES
999  |  CDH1  |  DISEASES
23604  |  DAPK2  |  DISEASES
2324  |  FLT4  |  DISEASES
9972  |  NUP153  |  DISEASES
4087  |  SMAD2  |  DISEASES
7528  |  YY1  |  DISEASES
495  |  ATP4A  |  DISEASES
3249  |  HPN  |  DISEASES
8503  |  PIK3R3  |  DISEASES
7077  |  TIMP2  |  DISEASES
7515  |  XRCC1  |  DISEASES
5595  |  MAPK3  |  DISEASES
6855  |  SYP  |  DISEASES
3552  |  IL1A  |  DISEASES
3553  |  IL1B  |  DISEASES
330  |  BIRC3  |  DISEASES
4072  |  EPCAM  |  DISEASES
8850  |  KAT2B  |  DISEASES
3791  |  KDR  |  DISEASES
943  |  TNFRSF8  |  DISEASES
5290  |  PIK3CA  |  DISEASES
1001  |  CDH3  |  DISEASES
51742  |  ARID4B  |  DISEASES
941  |  CD80  |  DISEASES
374  |  AREG  |  DISEASES
2247  |  FGF2  |  DISEASES
3589  |  IL11  |  DISEASES
7474  |  WNT5A  |  DISEASES
6774  |  STAT3  |  DISEASES
57110  |  HRASLS  |  DISEASES
3383  |  ICAM1  |  DISEASES
683  |  BST1  |  DISEASES
4171  |  MCM2  |  DISEASES
4437  |  MSH3  |  DISEASES
1950  |  EGF  |  DISEASES
64374  |  SIL1  |  DISEASES
7365  |  UGT2B10  |  DISEASES
127  |  ADH4  |  DISEASES
5243  |  ABCB1  |  DISEASES
29999  |  FSCN3  |  DISEASES
8379  |  MAD1L1  |  DISEASES
6425  |  SFRP5  |  DISEASES
7078  |  TIMP3  |  DISEASES
8549  |  LGR5  |  DISEASES
1017  |  CDK2  |  DISEASES
2065  |  ERBB3  |  DISEASES
2252  |  FGF7  |  DISEASES
3480  |  IGF1R  |  DISEASES
8826  |  IQGAP1  |  DISEASES
55040  |  EPN3  |  DISEASES
10140  |  TOB1  |  DISEASES
1000  |  CDH2  |  DISEASES
2627  |  GATA6  |  DISEASES
7157  |  TP53  |  DISEASES
2064  |  ERBB2  |  DISEASES
207  |  AKT1  |  DISEASES
8915  |  BCL10  |  DISEASES
6282  |  S100A11  |  DISEASES
388  |  RHOB  |  DISEASES
151230  |  KLHL23  |  DISEASES
10550  |  ARL6IP5  |  DISEASES
6167  |  RPL37  |  DISEASES
6502  |  SKP2  |  DISEASES
1956  |  EGFR  |  DISEASES
2041  |  EPHA1  |  DISEASES
53336  |  CPXCR1  |  DISEASES
8795  |  TNFRSF10B  |  DISEASES
85479  |  DNAJC5B  |  DISEASES
1030  |  CDKN2B  |  DISEASES
4851  |  NOTCH1  |  DISEASES
710  |  SERPING1  |  DISEASES
6876  |  TAGLN  |  DISEASES
4319  |  MMP10  |  DISEASES
7424  |  VEGFC  |  DISEASES
3606  |  IL18  |  DISEASES
5805  |  PTS  |  DISEASES
55294  |  FBXW7  |  DISEASES
2043  |  EPHA4  |  DISEASES
2321  |  FLT1  |  DISEASES
10413  |  YAP1  |  DISEASES
8404  |  SPARCL1  |  DISEASES
651  |  BMP3  |  DISEASES
7345  |  UCHL1  |  DISEASES
351  |  APP  |  DISEASES
81552  |  VOPP1  |  DISEASES
6782  |  HSPA13  |  DISEASES
389  |  RHOC  |  DISEASES
843  |  CASP10  |  DISEASES
10  |  NAT2  |  DISEASES
7074  |  TIAM1  |  DISEASES
4838  |  NODAL  |  DISEASES
6750  |  SST  |  DISEASES
123803  |  NTAN1  |  DISEASES
5468  |  PPARG  |  DISEASES
64146  |  PDF  |  DISEASES
3815  |  KIT  |  DISEASES
9133  |  CCNB2  |  DISEASES
144406  |  WDR66  |  DISEASES
8365  |  HIST1H4H  |  DISEASES
50848  |  F11R  |  DISEASES
5304  |  PIP  |  DISEASES
7032  |  TFF2  |  DISEASES
7031  |  TFF1  |  DISEASES
84988  |  PPP1R16A  |  DISEASES
84911  |  ZNF382  |  DISEASES
581  |  BAX  |  DISEASES
3856  |  KRT8  |  DISEASES
6159  |  RPL29  |  DISEASES
10630  |  PDPN  |  DISEASES
23528  |  ZNF281  |  DISEASES
2215  |  FCGR3B  |  DISEASES
51127  |  TRIM17  |  DISEASES
129401  |  NUP35  |  DISEASES
2019  |  EN1  |  DISEASES
27306  |  HPGDS  |  DISEASES
3577  |  CXCR1  |  DISEASES
64320  |  RNF25  |  DISEASES
50852  |  TRAT1  |  DISEASES
213  |  ALB  |  DISEASES
6997  |  TDGF1  |  DISEASES
150159  |  SLC9B1  |  DISEASES
4486  |  MST1R  |  DISEASES
308  |  ANXA5  |  DISEASES
3248  |  HPGD  |  DISEASES
1437  |  CSF2  |  DISEASES
55568  |  GALNT10  |  DISEASES
90390  |  MED30  |  DISEASES
5001  |  ORC5  |  DISEASES
216  |  ALDH1A1  |  DISEASES
64753  |  CCDC136  |  DISEASES
360  |  AQP3  |  DISEASES
5702  |  PSMC3  |  DISEASES
3611  |  ILK  |  DISEASES
5055  |  SERPINB2  |  DISEASES
7184  |  HSP90B1  |  DISEASES
4314  |  MMP3  |  DISEASES
4837  |  NNMT  |  DISEASES
5347  |  PLK1  |  DISEASES
5245  |  PHB  |  DISEASES
29123  |  ANKRD11  |  DISEASES
1548  |  CYP2A6  |  DISEASES
8000  |  PSCA  |  DISEASES
1613  |  DAPK3  |  DISEASES
90990  |  KIFC2  |  DISEASES
83547  |  RILP  |  DISEASES
3489  |  IGFBP6  |  DISEASES
4255  |  MGMT  |  DISEASES
9839  |  ZEB2  |  DISEASES
699  |  BUB1  |  DISEASES
598  |  BCL2L1  |  DISEASES
8796  |  SCEL  |  DISEASES
3479  |  IGF1  |  DISEASES
5734  |  PTGER4  |  DISEASES
3308  |  HSPA4  |  DISEASES
255738  |  PCSK9  |  DISEASES
3688  |  ITGB1  |  DISEASES
10960  |  LMAN2  |  DISEASES
8988  |  HSPB3  |  DISEASES
51237  |  MZB1  |  DISEASES
219417  |  OR8U1  |  DISEASES
7764  |  ZNF217  |  DISEASES
28991  |  COMMD5  |  DISEASES
1495  |  CTNNA1  |  DISEASES
79192  |  IRX1  |  DISEASES
1051  |  CEBPB  |  DISEASES
2353  |  FOS  |  DISEASES
4968  |  OGG1  |  DISEASES
125  |  ADH1B  |  DISEASES
256309  |  CCDC110  |  DISEASES
23627  |  PRND  |  DISEASES
4135  |  MAP6  |  DISEASES
29930  |  PCDHB1  |  DISEASES
4176  |  MCM7  |  DISEASES
54205  |  CYCS  |  DISEASES
51162  |  EGFL7  |  DISEASES
27087  |  B3GAT1  |  DISEASES
4323  |  MMP14  |  DISEASES
26579  |  MYEOV  |  DISEASES
3872  |  KRT17  |  DISEASES
2147  |  F2  |  DISEASES
89792  |  GAL3ST3  |  DISEASES
9940  |  DLEC1  |  DISEASES
5340  |  PLG  |  DISEASES
6596  |  HLTF  |  DISEASES
3219  |  HOXB9  |  DISEASES
5222  |  PGA5  |  DISEASES
7015  |  TERT  |  DISEASES
3265  |  HRAS  |  DISEASES
947  |  CD34  |  DISEASES
836  |  CASP3  |  DISEASES
1163  |  CKS1B  |  DISEASES
2944  |  GSTM1  |  DISEASES
3172  |  HNF4A  |  DISEASES
10009  |  ZBTB33  |  DISEASES
998  |  CDC42  |  DISEASES
27122  |  DKK3  |  DISEASES
56475  |  RPRM  |  DISEASES
10692  |  RRH  |  DISEASES
7298  |  TYMS  |  DISEASES
1604  |  CD55  |  DISEASES
8560  |  DEGS1  |  DISEASES
23512  |  SUZ12  |  DISEASES
4233  |  MET  |  DISEASES
494115  |  RBMXL1  |  DISEASES
4684  |  NCAM1  |  DISEASES
637  |  BID  |  DISEASES
54984  |  PINX1  |  DISEASES
10892  |  MALT1  |  DISEASES
3579  |  CXCR2  |  DISEASES
8834  |  TMEM11  |  DISEASES
80381  |  CD276  |  DISEASES
8289  |  ARID1A  |  DISEASES
995  |  CDC25C  |  DISEASES
6867  |  TACC1  |  DISEASES
89941  |  RHOT2  |  DISEASES
3039  |  HBA1  |  DISEASES
4312  |  MMP1  |  DISEASES
923  |  CD6  |  DISEASES
6657  |  SOX2  |  DISEASES
7706  |  TRIM25  |  DISEASES
56992  |  KIF15  |  DISEASES
3309  |  HSPA5  |  DISEASES
162963  |  ZNF610  |  DISEASES
9235  |  IL32  |  DISEASES
2932  |  GSK3B  |  DISEASES
80031  |  SEMA6D  |  DISEASES
5241  |  PGR  |  DISEASES
1272  |  CNTN1  |  DISEASES
93661  |  CAPZA3  |  DISEASES
168620  |  BHLHA15  |  DISEASES
4661  |  MYT1  |  DISEASES
84864  |  MINA  |  DISEASES
346389  |  MACC1  |  DISEASES
1789  |  DNMT3B  |  DISEASES
3855  |  KRT7  |  DISEASES
200504  |  GKN2  |  DISEASES
6667  |  SP1  |  DISEASES
55803  |  ADAP2  |  DISEASES
56849  |  TCEAL7  |  DISEASES
1915  |  EEF1A1  |  DISEASES
6753  |  SSTR3  |  DISEASES
842  |  CASP9  |  DISEASES
11099  |  PTPN21  |  DISEASES
4978  |  OPCML  |  DISEASES
30834  |  ZNRD1  |  DISEASES
926  |  CD8B  |  DISEASES
2520  |  GAST  |  DISEASES
79191  |  IRX3  |  DISEASES
942  |  CD86  |  DISEASES
5915  |  RARB  |  DISEASES
4088  |  SMAD3  |  DISEASES
682  |  BSG  |  DISEASES
5641  |  LGMN  |  DISEASES
245908  |  DEFB105A  |  DISEASES
196528  |  ARID2  |  DISEASES
51738  |  GHRL  |  DISEASES
504180  |  DEFB105B  |  DISEASES
887  |  CCKBR  |  DISEASES
885  |  CCK  |  DISEASES
283  |  ANG  |  DISEASES
375318  |  AQP12A  |  DISEASES
9166  |  EBAG9  |  DISEASES
3091  |  HIF1A  |  DISEASES
92140  |  MTDH  |  DISEASES
2246  |  FGF1  |  DISEASES
23583  |  SMUG1  |  DISEASES
7430  |  EZR  |  DISEASES
5329  |  PLAUR  |  DISEASES
63826  |  SRR  |  DISEASES
4697  |  NDUFA4  |  DISEASES
3329  |  HSPD1  |  DISEASES
5781  |  PTPN11  |  DISEASES
4089  |  SMAD4  |  DISEASES
1508  |  CTSB  |  DISEASES
2272  |  FHIT  |  DISEASES
1364  |  CLDN4  |  DISEASES
259307  |  IL4I1  |  DISEASES
388228  |  SBK1  |  DISEASES
8360  |  HIST1H4D  |  DISEASES
7517  |  XRCC3  |  DISEASES
864  |  RUNX3  |  DISEASES
5170  |  PDPK1  |  DISEASES
8045  |  RASSF7  |  DISEASES
1499  |  CTNNB1  |  DISEASES
4734  |  NEDD4  |  DISEASES
538  |  ATP7A  |  DISEASES
6227  |  RPS21  |  DISEASES
5562  |  PRKAA1  |  DISEASES
6275  |  S100A4  |  DISEASES
8294  |  HIST1H4I  |  DISEASES
5988  |  RFPL1  |  DISEASES
5154  |  PDGFA  |  DISEASES
8363  |  HIST1H4J  |  DISEASES
55107  |  ANO1  |  DISEASES
80781  |  COL18A1  |  DISEASES
331  |  XIAP  |  DISEASES
355  |  FAS  |  DISEASES
5265  |  SERPINA1  |  DISEASES
8368  |  HIST1H4L  |  DISEASES
84458  |  LCOR  |  DISEASES
23201  |  FAM168A  |  DISEASES
30968  |  STOML2  |  DISEASES
4100  |  MAGEA1  |  DISEASES
3187  |  HNRNPH1  |  DISEASES
3482  |  IGF2R  |  DISEASES
2980  |  GUCA2A  |  DISEASES
11186  |  RASSF1  |  DISEASES
51161  |  C3orf18  |  DISEASES
60  |  ACTB  |  DISEASES
8362  |  HIST1H4K  |  DISEASES
121504  |  HIST4H4  |  DISEASES
1612  |  DAPK1  |  DISEASES
1510  |  CTSE  |  DISEASES
26136  |  TES  |  DISEASES
6714  |  SRC  |  DISEASES
1969  |  EPHA2  |  DISEASES
841  |  CASP8  |  DISEASES
55319  |  TMA16  |  DISEASES
10004  |  NAALADL1  |  DISEASES
7048  |  TGFBR2  |  DISEASES
11199  |  ANXA10  |  DISEASES
1786  |  DNMT1  |  DISEASES
79683  |  ZDHHC14  |  DISEASES
4192  |  MDK  |  DISEASES
8359  |  HIST1H4A  |  DISEASES
6693  |  SPN  |  DISEASES
2157  |  F8  |  DISEASES
1366  |  CLDN7  |  DISEASES
5599  |  MAPK8  |  DISEASES
8367  |  HIST1H4E  |  DISEASES
4311  |  MME  |  DISEASES
4326  |  MMP17  |  DISEASES
415116  |  PIM3  |  DISEASES
54106  |  TLR9  |  DISEASES
6935  |  ZEB1  |  DISEASES
7150  |  TOP1  |  DISEASES
2475  |  MTOR  |  DISEASES
2736  |  GLI2  |  DISEASES
5742  |  PTGS1  |  DISEASES
6136  |  RPL12  |  DISEASES
919  |  CD247  |  DISEASES
10724  |  MGEA5  |  DISEASES
55388  |  MCM10  |  DISEASES
4514  |  MT-CO3  |  DISEASES
3880  |  KRT19  |  DISEASES
8678  |  BECN1  |  DISEASES
23038  |  WDTC1  |  DISEASES
142  |  PARP1  |  DISEASES
1380  |  CR2  |  DISEASES
8444  |  DYRK3  |  DISEASES
3814  |  KISS1  |  DISEASES
80177  |  MYCT1  |  DISEASES
5788  |  PTPRC  |  DISEASES
5743  |  PTGS2  |  DISEASES
7175  |  TPR  |  DISEASES
10370  |  CITED2  |  DISEASES
356  |  FASLG  |  DISEASES
57147  |  SCYL3  |  DISEASES
6375  |  XCL1  |  DISEASES
5451  |  POU2F1  |  DISEASES
2214  |  FCGR3A  |  DISEASES
1490  |  CTGF  |  DISEASES
5824  |  PEX19  |  DISEASES
4582  |  MUC1  |  DISEASES
1942  |  EFNA1  |  DISEASES
6273  |  S100A2  |  DISEASES
6277  |  S100A6  |  DISEASES
6279  |  S100A8  |  DISEASES
8991  |  SELENBP1  |  DISEASES
1520  |  CTSS  |  DISEASES
8661  |  EIF3A  |  DISEASES
554313  |  HIST2H4B  |  DISEASES
8370  |  HIST2H4A  |  DISEASES
22986  |  SORCS3  |  DISEASES
8771  |  TNFRSF6B  |  DISEASES
393  |  ARHGAP4  |  DISEASES
10360  |  NPM3  |  DISEASES
1806  |  DPYD  |  DISEASES
4102  |  MAGEA3  |  DISEASES
959  |  CD40LG  |  DISEASES
1791  |  DNTT  |  DISEASES
3725  |  JUN  |  DISEASES
11124  |  FAF1  |  DISEASES
5728  |  PTEN  |  DISEASES
10103  |  TSPAN1  |  DISEASES
7422  |  VEGFA  |  DISEASES
4318  |  MMP9  |  DISEASES
100132074  |  FOXO6  |  DISEASES
5328  |  PLAU  |  DISEASES
3188  |  HNRNPH2  |  DISEASES
5225  |  PGC  |  DISEASES
653121  |  ZBTB8A  |  DISEASES
55869  |  HDAC8  |  DISEASES
2833  |  CXCR3  |  DISEASES
51552  |  RAB14  |  DISEASES
7185  |  TRAF1  |  DISEASES
7099  |  TLR4  |  DISEASES
5774  |  PTPN3  |  DISEASES
8518  |  IKBKAP  |  DISEASES
9314  |  KLF4  |  DISEASES
5698  |  PSMB9  |  DISEASES
7046  |  TGFBR1  |  DISEASES
55920  |  RCC2  |  DISEASES
728239  |  MAGED4  |  DISEASES
23013  |  SPEN  |  DISEASES
3397  |  ID1  |  DISEASES
50943  |  FOXP3  |  DISEASES
3190  |  HNRNPK  |  DISEASES
5514  |  PPP1R10  |  DISEASES
2017  |  CTTN  |  DISEASES
4524  |  MTHFR  |  DISEASES
648  |  BMI1  |  DISEASES
11074  |  TRIM31  |  DISEASES
548313  |  SSX4B  |  DISEASES
6759  |  SSX4  |  DISEASES
3274  |  HRH2  |  DISEASES
8366  |  HIST1H4B  |  DISEASES
55735  |  DNAJC11  |  DISEASES
688  |  KLF5  |  DISEASES
8361  |  HIST1H4F  |  DISEASES
8364  |  HIST1H4C  |  DISEASES
56287  |  GKN1  |  DISEASES
8434  |  RECK  |  DISEASES
4609  |  MYC  |  DISEASES
2857  |  GPR34  |  DISEASES
22929  |  SEPHS1  |  DISEASES
646480  |  FABP9  |  DISEASES
168400  |  DDX53  |  DISEASES
9770  |  RASSF2  |  DISEASES
1874  |  E2F4  |  DISEASES
4739  |  NEDD9  |  DISEASES
1543  |  CYP1A1  |  DISEASES
81567  |  TXNDC5  |  DISEASES
23586  |  DDX58  |  DISEASES
675  |  BRCA2  |  DISEASES
4507  |  MTAP  |  DISEASES
1045  |  CDX2  |  DISEASES
3486  |  IGFBP3  |  DISEASES
6443  |  SGCB  |  DISEASES
29126  |  CD274  |  DISEASES
3717  |  JAK2  |  DISEASES
254251  |  LCORL  |  DISEASES
1761  |  DMRT1  |  DISEASES
6624  |  FSCN1  |  DISEASES
9037  |  SEMA5A  |  DISEASES
60312  |  AFAP1  |  DISEASES
11200  |  CHEK2  |  DISEASES
26524  |  LATS2  |  DISEASES
5268  |  SERPINB5  |  DISEASES
1133  |  CHRM5  |  DISEASES
3875  |  KRT18  |  DISEASES
23779  |  ARHGAP8  |  DISEASES
10477  |  UBE2E3  |  DISEASES
80196  |  RNF34  |  DISEASES
7187  |  TRAF3  |  DISEASES
12  |  SERPINA3  |  DISEASES
4831  |  NME2  |  DISEASES
27032  |  ATP2C1  |  DISEASES
5361  |  PLXNA1  |  DISEASES
9055  |  PRC1  |  DISEASES
2719  |  GPC3  |  DISEASES
79633  |  FAT4  |  DISEASES
8513  |  LIPF  |  DISEASES
6696  |  SPP1  |  DISEASES
1365  |  CLDN3  |  DISEASES
983  |  CDK1  |  DISEASES
2919  |  CXCL1  |  DISEASES
174  |  AFP  |  DISEASES
6387  |  CXCL12  |  DISEASES
51147  |  ING4  |  DISEASES
80380  |  PDCD1LG2  |  DISEASES
5609  |  MAP2K7  |  DISEASES
4599  |  MX1  |  DISEASES
2950  |  GSTP1  |  DISEASES
1500  |  CTNND1  |  DISEASES
8091  |  HMGA2  |  DISEASES
5970  |  RELA  |  DISEASES
2011  |  MARK2  |  DISEASES
7018  |  TF  |  DISEASES
89958  |  SAPCD2  |  DISEASES
7852  |  CXCR4  |  DISEASES
50626  |  CYHR1  |  DISEASES
1630  |  DCC  |  DISEASES
6336  |  SCN10A  |  DISEASES
23256  |  SCFD1  |  DISEASES
3481  |  IGF2  |  DISEASES
55743  |  CHFR  |  DISEASES
51292  |  GMPR2  |  DISEASES
3833  |  KIFC1  |  DISEASES
23210  |  JMJD6  |  DISEASES
25801  |  GCA  |  DISEASES
1029  |  CDKN2A  |  DISEASES
26354  |  GNL3  |  DISEASES
720  |  C4A  |  DISEASES
55683  |  KANSL3  |  DISEASES
79935  |  CNTD2  |  DISEASES
56616  |  DIABLO  |  DISEASES
960  |  CD44  |  DISEASES
7124  |  TNF  |  DISEASES
3491  |  CYR61  |  DISEASES
387  |  RHOA  |  DISEASES
11319  |  ECD  |  DISEASES
340547  |  VSIG1  |  DISEASES
55353  |  LAPTM4B  |  DISEASES
6173  |  RPL36A  |  DISEASES
90338  |  ZNF160  |  DISEASES
4588  |  MUC6  |  DISEASES
121256  |  TMEM132D  |  DISEASES
100131827  |  ZNF717  |  DISEASES
834  |  CASP1  |  DISEASES
2263  |  FGFR2  |  DISEASES
3925  |  STMN1  |  DISEASES
7153  |  TOP2A  |  DISEASES
79635  |  CCDC121  |  DISEASES
3586  |  IL10  |  DISEASES
114132  |  SIGLEC11  |  DISEASES
728090  |  CT47A2  |  DISEASES
4583  |  MUC2  |  DISEASES
8842  |  PROM1  |  DISEASES
721  |  C4B  |  DISEASES
6513  |  SLC2A1  |  DISEASES
26261  |  FBXO24  |  DISEASES
10201  |  NME6  |  DISEASES
1849  |  DUSP7  |  DISEASES
4193  |  MDM2  |  DISEASES
4585  |  MUC4  |  DISEASES
672  |  BRCA1  |  DISEASES
26355  |  FAM162A  |  DISEASES
25816  |  TNFAIP8  |  DISEASES
285782  |  CAGE1  |  DISEASES
170960  |  ZNF721  |  DISEASES
7033  |  TFF3  |  DISEASES
4586  |  MUC5AC  |  DISEASES
59082  |  CARD18  |  DISEASES
727897  |  MUC5B  |  DISEASES
152687  |  ZNF595  |  DISEASES
140836  |  BANF2  |  DISEASES
5365  |  PLXNB3  |  DISEASES
84133  |  ZNRF3  |  DISEASES
605  |  BCL7A  |  DISEASES
1649  |  DDIT3  |  DISEASES
8437  |  RASAL1  |  DISEASES
2079  |  ERH  |  DISEASES
90416  |  C15orf57  |  DISEASES
567  |  B2M  |  DISEASES
321  |  APBA2  |  DISEASES
81831  |  NETO2  |  DISEASES
51741  |  WWOX  |  DISEASES
3316  |  HSPB2  |  DISEASES
57733  |  GBA3  |  DISEASES
154860  |  FEZF1-AS1  |  DISEASES
104326057  |  GACAT1  |  DISEASES
102723099  |  GHET1  |  DISEASES
100124700  |  HOTAIR  |  DISEASES
100506465  |  LINC01234  |  DISEASES
378938  |  MALAT1  |  DISEASES
104472713  |  PCAT29  |  DISEASES
100093630  |  SNHG8  |  DISEASES
257000  |  TINCR  |  DISEASES
Locus(Waiting for update.)
Disease ID 639
Disease gastric cancer
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:119)
HP:0002664  |  Neoplasia  |  273
HP:0005202  |  Helicobacter pylori infection  |  24
HP:0005263  |  Gastritis  |  23
HP:0001541  |  Ascites  |  18
HP:0030731  |  Carcinoma  |  15
HP:0000718  |  Aggressive behaviour  |  13
HP:0004398  |  Peptic ulcer  |  11
HP:0004326  |  Cachexia  |  6
HP:0005521  |  Disseminated intravascular coagulation  |  6
HP:0005231  |  Chronic gastritis  |  5
HP:0005214  |  Bowel obstruction  |  5
HP:0002021  |  Pyloric stenosis  |  5
HP:0002665  |  Lymphoma  |  5
HP:0002013  |  Emesis  |  4
HP:0005584  |  Renal cell carcinoma  |  4
HP:0002588  |  Duodenal ulcer  |  4
HP:0000822  |  Hypertension  |  4
HP:0003002  |  Breast carcinoma  |  4
HP:0000819  |  Diabetes mellitus  |  4
HP:0001903  |  Anemia  |  4
HP:0003003  |  Colon cancer  |  4
HP:0002586  |  Peritonitis  |  4
HP:0001696  |  Situs inversus totalis  |  3
HP:0001409  |  Portal hypertension  |  3
HP:0002018  |  Nausea  |  3
HP:0001513  |  Obesity  |  3
HP:0001907  |  Thromboembolic disease  |  3
HP:0004796  |  Gastrointestinal obstruction  |  3
HP:0001394  |  Hepatic cirrhosis  |  3
HP:0000952  |  Yellow skin  |  2
HP:0005200  |  Retroperitoneal fibrosis  |  2
HP:0000716  |  Depression  |  2
HP:0002582  |  Chronic atrophic gastritis  |  2
HP:0000083  |  Renal insufficiency  |  2
HP:0002863  |  Myelodysplastic syndrome  |  2
HP:0002017  |  Nausea and vomiting  |  2
HP:0002721  |  Immunodeficiency  |  2
HP:0001298  |  Encephalopathy  |  2
HP:0001945  |  Fever  |  2
HP:0012622  |  Chronic kidney disease  |  2
HP:0003774  |  End-stage renal failure  |  2
HP:0011459  |  Esophageal carcinoma  |  2
HP:0003128  |  Lactic acidosis  |  2
HP:0100768  |  Choriocarcinoma  |  2
HP:0002860  |  Squamous cell carcinoma  |  2
HP:0012125  |  Prostate cancer  |  2
HP:0001941  |  acidemia  |  2
HP:0002592  |  Stomach ulcer  |  2
HP:0002633  |  Vasculitis  |  2
HP:0002894  |  Neoplasia of the pancreas  |  2
HP:0100723  |  Gastrointestinal stroma tumor  |  2
HP:0000939  |  Osteoporosis  |  2
HP:0100502  |  Vitamin B12 deficiency  |  2
HP:0002090  |  Pneumonia  |  1
HP:0001081  |  Gallstones  |  1
HP:0004395  |  Malnutrition  |  1
HP:0005435  |  Impaired T cell function  |  1
HP:0002315  |  Headaches  |  1
HP:0100633  |  Inflammation of the esophagus  |  1
HP:0002580  |  Volvulus  |  1
HP:0000739  |  Anxiety  |  1
HP:0002566  |  Intestinal malrotation  |  1
HP:0001915  |  Aplastic anemia  |  1
HP:0005222  |  Bowel diverticulosis  |  1
HP:0000131  |  Uterine leiomyoma  |  1
HP:0005550  |  Chronic lymphatic leukemia  |  1
HP:0011880  |  Acute disseminated intravascular coagulation  |  1
HP:0000787  |  Renal calculi  |  1
HP:0001873  |  Low platelet count  |  1
HP:0001657  |  Prolonged QT interval  |  1
HP:0003765  |  Psoriasis  |  1
HP:0000126  |  Hydronephrosis  |  1
HP:0002571  |  Achalasia  |  1
HP:0045038  |  Primary gastric lymphoma  |  1
HP:0001892  |  Bleeding diathesis  |  1
HP:0001909  |  Leukemia  |  1
HP:0002890  |  Thyroid carcinoma  |  1
HP:0001701  |  Pericarditis  |  1
HP:0012531  |  Pain  |  1
HP:0002583  |  Colitis  |  1
HP:0000855  |  Insulin resistance  |  1
HP:0002248  |  Vomitting blood  |  1
HP:0004322  |  Stature below 3rd percentile  |  1
HP:0000771  |  Gynaecomastia  |  1
HP:0030248  |  Blood clot in mesentertic vein  |  1
HP:0001082  |  Cholecystitis  |  1
HP:0012378  |  Fatigue  |  1
HP:0001635  |  Congestive heart failure  |  1
HP:0030242  |  Blood clot in portal vein  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0100584  |  Endocarditis  |  1
HP:0001297  |  Cerebral vascular events  |  1
HP:0001891  |  Iron-deficiency anemia  |  1
HP:0030154  |  Gall bladder perforation  |  1
HP:0002895  |  Papillary thyroid carcinoma  |  1
HP:0002140  |  Ischemic stroke  |  1
HP:0000833  |  Glucose intolerance  |  1
HP:0100523  |  Hepatic abscess  |  1
HP:0006532  |  Pneumonia, recurrent episodes  |  1
HP:0002896  |  Liver cancer  |  1
HP:0002725  |  Systemic lupus erythematosus  |  1
HP:0001987  |  Hyperammonemia  |  1
HP:0100658  |  Bacterial infection of skin  |  1
HP:0010280  |  Stomatitis  |  1
HP:0006510  |  Chronic obstructive pulmonary disease  |  1
HP:0004936  |  Blood clot in vein  |  1
HP:0001901  |  Abnormally shaped erythrocytes  |  1
HP:0100570  |  Carcinoid tumor  |  1
HP:0001943  |  Hypoglycemia  |  1
HP:0001875  |  Neutropenia  |  1
HP:0012330  |  Pyelonephritis  |  1
HP:0009725  |  Bladder neoplasm  |  1
HP:0100845  |  Anaphylactic shock  |  1
HP:0001748  |  Polysplenia  |  1
HP:0001250  |  Seizures  |  1
HP:0001548  |  Overgrowth  |  1
HP:0100279  |  Ulcerative colitis  |  1
HP:0012188  |  Hyperemesis gravidarum  |  1
HP:0001971  |  Hypersplenism  |  1
Disease ID 639
Disease gastric cancer
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:61)
C0009450  |  infection  |  83
C0494165  |  liver metastasis  |  43
C0494165  |  liver metastases  |  32
C0686619  |  lymph node metastases  |  29
C0205699  |  carcinomatosis  |  28
C1332128  |  peritoneal carcinomatosis  |  25
C0850666  |  helicobacter pylori infection  |  24
C0017152  |  gastritis  |  23
C0850666  |  h. pylori infection  |  15
C0346989  |  peritoneal metastases  |  13
C0153690  |  bone metastasis  |  11
C0153690  |  bone metastases  |  10
C0001418  |  adenocarcinoma  |  10
C0220656  |  malignant ascites  |  9
C0242379  |  lung cancer  |  6
C0494165  |  hepatic metastases  |  6
C0006625  |  cachexia  |  6
C0036527  |  ovarian metastasis  |  5
C0014859  |  esophageal cancer  |  5
C0085695  |  chronic gastritis  |  5
C0024232  |  lymphatic metastasis  |  5
C0002871  |  anemia  |  4
C0220654  |  meningeal carcinomatosis  |  4
C0494165  |  hepatic metastasis  |  4
C0940937  |  precancerous lesions  |  4
C1541124  |  pyloric obstruction  |  3
C0021311  |  infections  |  3
C0282207  |  cronkhite-canada syndrome  |  3
C0019080  |  hemorrhage  |  3
C0013395  |  dyspepsia  |  3
C0220650  |  brain metastasis  |  3
C0040053  |  thrombosis  |  3
C0040038  |  thromboembolism  |  3
C0162316  |  iron deficiency  |  2
C0149678  |  ebv infection  |  2
C0021051  |  immunodeficiency  |  2
C0009404  |  colorectal neoplasms  |  2
C0002793  |  dedifferentiation  |  2
C0016169  |  fistula  |  2
C0346993  |  breast metastasis  |  2
C0026986  |  myelodysplastic syndrome  |  2
C1519670  |  tumor angiogenesis  |  2
C0220650  |  brain metastases  |  2
C0036527  |  ovarian metastases  |  2
C0018926  |  hematemesis  |  1
C0042487  |  venous thrombosis  |  1
C0007177  |  cardiac tamponade  |  1
C0267179  |  gastrocolic fistula  |  1
C0235884  |  gastric perforation  |  1
C2242595  |  mucosal atrophy  |  1
C0235329  |  small bowel obstruction  |  1
C0349529  |  gastric carcinoid  |  1
C0162429  |  malnutrition  |  1
C0850666  |  h pylori infection  |  1
C0029896  |  ent disease  |  1
C0024141  |  systemic lupus erythematosus  |  1
C0153687  |  skin metastasis  |  1
C0153676  |  lung metastases  |  1
C1611183  |  carcinomatous peritonitis  |  1
C0149678  |  epstein-barr virus infection  |  1
C0002892  |  pernicious anemia  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:413)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs10052016239010647015TERTumls:C0024623BeFreeAfter combining these two studies, we found that the G allele of rs10052016 (at 132 kb upstream of TERT) was significantly associated with a decreased risk of gastric cancer (OR = 0.76, 95% CI = 0.67-0.87, P = 5.35 × 10(-5)).0.0046145122014SLC6A351427996AG
rs10421916230289003640INSL3umls:C0024623BeFreeINSL3 rs10421916 and rs11088680 had both a 0.8-fold decreased OR for gastric cancer (95% CIs = 0.7-0.97; and 0.7-0.9, respectively).0.0002714422012INSL31917818178AG
rs1042522251900207157TP53umls:C0024623BeFreeHowever, no overall association was found between the TP53 Arg72Pro polymorphism and gastric cancer risk.0.0842778022014TP53177676154GT,C
rs1042522226316717157TP53umls:C0024623BeFreePro variant of TP53 Arg72Pro contributes to gastric cancer risk in Asians: evidence from a meta-analysis.0.0842778022012TP53177676154GT,C
rs1042522213762657157TP53umls:C0024623BeFreeThis meta-analysis suggests that Pro allele in P53 Arg72Pro is significantly associated with the increased risks of digestive tract cancers, especially for Asians, and for gastric cancer, colorectal cancer and gallbladder and pancreatic cancer.0.0842778022011TP53177676154GT,C
rs1042522227802997157TP53umls:C0024623BeFreeAssociation of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis.0.0842778022012TP53177676154GT,C
rs1042522229011237157TP53umls:C0024623BeFreeUpdated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.0.0842778022012TP53177676154GT,C
rs1045642248154415243ABCB1umls:C0024623BeFreeLack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis.0.0145059712015ABCB1787509329AT,G
rs1045642222963925243ABCB1umls:C0024623BeFreeMDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy.0.0145059712011ABCB1787509329AT,G
rs1045642226414025243ABCB1umls:C0024623BeFreeNo correlation was observed between the C3435T polymorphism of the MDR1 gene and GC risk or prognosis in the population studied.0.0145059712012ABCB1787509329AT,G
rs1045642186443895243ABCB1umls:C0024623BeFreeMDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.0.0145059712008ABCB1787509329AT,G
rs10499563244603203569IL6umls:C0024623BeFreeIL-6-6331 (T/C, rs10499563) is associated with decreased risk of gastric cancer in Northern Chinese.0.0134961492014NA722720869TC
rs10505477250467485462POU5F1Bumls:C0024623BeFreeOur preliminary study indicates for the first time that POU5F1P1 rs10505477 is correlated with survival of gastric cancer patients who receving cisplatin-based chemotherapy after gastrectomy.0.0005428842014CASC88127395198AG
rs1050967026554163596BCL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0152007452016PLCE11094308190AG
rs10509670265541638000PSCAumls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0097719072016PLCE11094308190AG
rs105096702655416351196PLCE1umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.1240716282016PLCE11094308190AG
rs1050967026554163252969NEIL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0005428842016PLCE11094308190AG
rs10511729252396441993ELAVL2umls:C0024623BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0008143262015LOC101929563923557229TG
rs1051740171643662052EPHX1umls:C0024623BeFreeWe found an increased risk of gastric cancer for homozygotes for C (histidine) variant in Y113H of EPHX1 (odds ratio, 1.91; 95% confidence interval, 1.19-3.07) compared with subjects with TC/TT.0.0029099162006EPHX11225831932TC
rs1051740235801252052EPHX1umls:C0024623BeFreeAssociation of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India.0.0029099162013EPHX11225831932TC
rs1052133227992964968OGG1umls:C0024623BeFreeLack of association between the hOGG1 Ser326Cys polymorphism and gastric cancer risk: a meta-analysis.0.0125299332012OGG1;CAMK139757089CG
rs1052133222964984968OGG1umls:C0024623BeFreeLack of association between Human Oxoguanine Glycosylase 1 (hOGG1) S326C polymorphism and the risk of gastric cancer: a meta-analysis.0.0125299332012OGG1;CAMK139757089CG
rs1052133208177634255MGMTumls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0067101022010OGG1;CAMK139757089CG
rs105213319147860328APEX1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0024429772009OGG1;CAMK139757089CG
rs1052133155960474968OGG1umls:C0024623BeFreehOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations.0.0125299332004OGG1;CAMK139757089CG
rs1052133208177634968OGG1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0125299332010OGG1;CAMK139757089CG
rs1052133208177632067ERCC1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0104343432010OGG1;CAMK139757089CG
rs1052133221146774968OGG1umls:C0024623BeFreeThe significant effects of hOGG1 Ser326Cys polymorphism on colorectal, breast, bladder, prostate, esophageal, and gastric cancer were not detected.0.0125299332011OGG1;CAMK139757089CG
rs1052133223437854968OGG1umls:C0024623BeFreeThe functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls.0.0125299332012OGG1;CAMK139757089CG
rs1052133208177632068ERCC2umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0119111052010OGG1;CAMK139757089CG
rs1052133191478607515XRCC1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0176113842009OGG1;CAMK139757089CG
rs1052133208177637517XRCC3umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0074484832010OGG1;CAMK139757089CG
rs1052133191478604968OGG1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0125299332009OGG1;CAMK139757089CG
rs1052133222941084968OGG1umls:C0024623BeFreeAssociation of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis.0.0125299332012OGG1;CAMK139757089CG
rs1052133224714924968OGG1umls:C0024623BeFreeLack of association between the 8-oxoguanine DNA glycosylase gene Ser326Cys polymorphism and gastric cancer: evidence from a meta-analysis.0.0125299332011OGG1;CAMK139757089CG
rs10629352342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013RPTOR1780966057TC
rs1073997124586594406881MIRLET7A1umls:C0024623BeFreeAn interaction effect of pri-let-7a-1 rs10739971 polymorphism with ERCC6 rs1917799 polymorphism was observed for the risk of gastric cancer (P interaction = 0.026); and interaction effects of pri-let-7a-1 rs10739971 polymorphism with PGC rs6458238 polymorphism (P interaction = 0.012) and PGC rs9471643 polymorphism (P interaction = 0.039) were observed for the risk of atrophic gastritis.0.0002714422014MIRLET7A1;MIRLET7F1994175398GA
rs10739971245865942074ERCC6umls:C0024623BeFreeThe interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.0.0005428842014MIRLET7A1;MIRLET7F1994175398GA
rs10739971245865945225PGCumls:C0024623BeFreeThe interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.0.0098155152014MIRLET7A1;MIRLET7F1994175398GA
rs10811474252396441993ELAVL2umls:C0024623BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0008143262015NA921114238AG
rs10983755250845127099TLR4umls:C0024623BeFreeEffect of the -2081G/A polymorphism of the TLR4 gene and its interaction with Helicobacter pylori infection on the risk of gastric cancer in Chinese individuals.0.0088816372015TLR49117702392GA
rs110662802566134957103C12orf5umls:C0024623BeFreeC12orf5 rs11066280 could be useful marker of survival assessment and individualized clinical therapy for gastric cancer, particularly among the intestinal-type gastric cancer.0.0002714422014HECTD412112379979TA
rs11088680230289003640INSL3umls:C0024623BeFreeINSL3 rs10421916 and rs11088680 had both a 0.8-fold decreased OR for gastric cancer (95% CIs = 0.7-0.97; and 0.7-0.9, respectively).0.0002714422012NA2113514758AG
rs1117087725261463442892MIR148Bumls:C0024623BeFreePolymorphisms of miR-148b rs11170877 and 12231393 and their haplotypes were predictive factors of susceptibility to GC.0.0005428842015COPZ11254340505AG
rs1120902625666505149233IL23Rumls:C0024623BeFreeVariants of IL23R gene were investigated for association with many diseases like chronic inflammatory disorders, RA, inflammatory bowel diseases and the susceptibility to the development of gastric cancer but no data are available concerning the association of IL23R gene (rs11209026) polymorphism with HCC development in HCV patients.0.0008143262015IL23R167240275GA
rs112090262566650584668FAM126Aumls:C0024623BeFreeVariants of IL23R gene were investigated for association with many diseases like chronic inflammatory disorders, RA, inflammatory bowel diseases and the susceptibility to the development of gastric cancer but no data are available concerning the association of IL23R gene (rs11209026) polymorphism with HCC development in HCV patients.0.0016286512015IL23R167240275GA
rs1130409191478604968OGG1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0125299332009APEX1;OSGEP1420456995TA,G
rs113040924349526328APEX1umls:C0024623BeFreeOur findings suggest that APEX1 Asp148Glu polymorphism might be a genetic risk factor for the development of gastric cancer.0.0024429772013APEX1;OSGEP1420456995TA,G
rs1130409191478607515XRCC1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0176113842009APEX1;OSGEP1420456995TA,G
rs113040925945024328APEX1umls:C0024623BeFreeThis meta-analysis suggests that the APE1 Asp148Glu polymorphism G allele is associated with an increased GI cancer risk, especially in gastric cancer.0.0024429772014APEX1;OSGEP1420456995TA,G
rs113040919147860328APEX1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0024429772009APEX1;OSGEP1420456995TA,G
rs1136201238445332064ERBB2umls:C0024623BeFreeAnalysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions.0.0701515552013ERBB21739723335AG,T
rs1136201238445331956EGFRumls:C0024623BeFreeOur data suggest that the EGFR-R521K and ERBB2-I655V polymorphisms are not suitable as markers for identifying individuals with a higher risk for developing gastric cancer in our population.0.030097712013ERBB21739723335AG,T
rs113641018716896142PARP1umls:C0024623BeFreePARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population.0.0027144192009PARP11226367601AG
rs113641022901183142PARP1umls:C0024623BeFreeADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.0.0027144192012PARP11226367601AG
rs1136410229011837515XRCC1umls:C0024623BeFreeADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.0.0176113842012PARP11226367601AG
rs1136410216124074313MMP2umls:C0024623BeFreeEpistasis between PARP1 rs1136410 and MMP2 rs243865 increased the risk of LNM of GC.0.0134202042011PARP11226367601AG
rs1143623216497245743PTGS2umls:C0024623BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0369597022011IL1B2112838252CG
rs1143623216497243553IL1Bumls:C0024623BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0646693122011IL1B2112838252CG
rs11536889207216257099TLR4umls:C0024623BeFreeThis study aimed to examine the associations of the miR-146a G/C (rs2910164) and TLR4 +3725 G/C (rs11536889) polymorphisms with the risk of Helicobacter pylori (H. pylori) infection, gastric atrophy, and gastric cancer in a Japanese population.0.0088816372011TLR49117715853GC
rs11536889249291427099TLR4umls:C0024623BeFreeIn multivariate analyses, TLR4 rs11536889 remained a risk factor for GC (OR: 3.58, 95% CI: 1.20-10.65).0.0088816372014TLR49117715853GC
rs1153688920721625406938MIR146Aumls:C0024623BeFreeThis study aimed to examine the associations of the miR-146a G/C (rs2910164) and TLR4 +3725 G/C (rs11536889) polymorphisms with the risk of Helicobacter pylori (H. pylori) infection, gastric atrophy, and gastric cancer in a Japanese population.0.0051573962011TLR49117715853GC
rs11536889235652264695NDUFA2umls:C0024623BeFreeTLR4 rs11536889 and CD14 -260 C/T are associated with non-cardia GC in Chinese.0.0021715352013TLR49117715853GC
rs11540654226316717157TP53umls:C0024623BeFreePro variant of TP53 Arg72Pro contributes to gastric cancer risk in Asians: evidence from a meta-analysis.0.0842778022012TP53177676040CT,G,A
rs11540654251900207157TP53umls:C0024623BeFreeHowever, no overall association was found between the TP53 Arg72Pro polymorphism and gastric cancer risk.0.0842778022014TP53177676040CT,G,A
rs11540654213762657157TP53umls:C0024623BeFreeThis meta-analysis suggests that Pro allele in P53 Arg72Pro is significantly associated with the increased risks of digestive tract cancers, especially for Asians, and for gastric cancer, colorectal cancer and gallbladder and pancreatic cancer.0.0842778022011TP53177676040CT,G,A
rs11540654229011237157TP53umls:C0024623BeFreeUpdated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.0.0842778022012TP53177676040CT,G,A
rs11540654227802997157TP53umls:C0024623BeFreeAssociation of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis.0.0842778022012TP53177676040CT,G,A
rs1161491325202115406938MIR146Aumls:C0024623BeFreeWe evaluated the associations of three selected SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (hsa-mir-196a2, hsa-mir-146a and hsa-mir-499) with the prognosis of advanced gastric cancers (GCs) treated by chemotherapy.0.0051573962014MIR196A21253991815CT
rs1161491321073609574501MIR499Aumls:C0024623BeFreeWe evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population.0.0010857672010MIR196A21253991815CT
rs1161491325795117406938MIR146Aumls:C0024623BeFreeIn the stratified analysis, in some subgroup, heterozygous miR-146a rs2910164 was associated with a decreased risk of gastric cancer; and the variant genotype of miR-196a-2 rs11614913 was associated with an increased risk.0.0051573962014MIR196A21253991815CT
rs1161491324379078406941MIR149umls:C0024623BeFreeWe found that the risk for GC was significantly higher for the carriers of miR-149 rs2292832CC (p = 0.009) and miR-196a2 rs11614913CC (p < 0.0001) genotypes, as well as for the carriers of the rs2910164/rs2292832/rs11614913 CCC and GTC haplotype (p < 0.0001 and p = 0.03, respectively).0.0010857672013MIR196A21253991815CT
rs1161491324379078406938MIR146Aumls:C0024623BeFreeThe aim of the study was to investigated whether three common miRNA polymorphisms [miR-146a C>G (rs2910164), miR-149 T>C (rs2292832), and miR-196a2 T>C (rs11614913)] are associated with the susceptibility and prognosis of gastric cancer (GC) in the Greek population.0.0051573962013MIR196A21253991815CT
rs1161491325202115574501MIR499Aumls:C0024623BeFreeWe evaluated the associations of three selected SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (hsa-mir-196a2, hsa-mir-146a and hsa-mir-499) with the prognosis of advanced gastric cancers (GCs) treated by chemotherapy.0.0010857672014MIR196A21253991815CT
rs11615255422282067ERCC1umls:C0024623BeFreeBy the Cox analysis, the CC genotype of ERCC1 rs11615, AA genotype of ERCC2 rs1799793, and CC genotype of NBN rs1805794 were significantly associated with a longer overall survival (OS) of gastric cancer.0.0104343432014ERCC11945420395AG
rs11615255422282068ERCC2umls:C0024623BeFreeIn conclusion, our results suggest that ERCC1 rs11615, ERCC2 rs1799793, and NBN rs1805794 polymorphisms in the DNA repair pathways may influence the response to chemotherapy and OS of gastric cancer.0.0119111052014ERCC11945420395AG
rs11615255422284683NBNumls:C0024623BeFreeIn conclusion, our results suggest that ERCC1 rs11615, ERCC2 rs1799793, and NBN rs1805794 polymorphisms in the DNA repair pathways may influence the response to chemotherapy and OS of gastric cancer.0.0029099162014ERCC11945420395AG
rs11792512538781053342IL17Dumls:C0024623BeFreeIn summary, our study demonstrates that the rs1179251 polymorphism of IL-22 was associated with an increased risk of GC and may influence the progression of GC.0.0002714422014IL22;LOC1053698181268251271CG
rs1210849725002346836CASP3umls:C0024623BeFreeIn analysis of gene polymorphism of caspase3 intrinsic apoptotic pathway and gastric cancer susceptibility, polymorphism of CASP3 rs4647693, CASP3 rs12108497 and CASP3 rs4647610 increased gastric cancer risk (rs4647693: ORGA 1.61, 95 % CI 1.06-2.28; rs12108497: ORTC 1.55, 95 % CI 1.09-2.18; ORCC 2.45, 95 % CI 1.08-4.16; rs4647610: ORAG 1.71, 95 % CI 1.14-2.31; ORGG 1.60, 95 % CI 1.23-2.34).0.0070574892015CASP3;PRIMPOL4184650403CT
rs12155758240238158000PSCAumls:C0024623BeFreeWe analyzed 3 SNPs in the PSCA gene (rs2294008, rs9297976 and rs12155758) which were previously found to be associated with GC risk in Europeans.0.0097719072013NA8142684467GA
rs121912664220041167157TP53umls:C0024623BeFreeTP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child: evidence for chimerism involving a common mutant founder haplotype: case report.0.0842778022011TP53177670699CT,G,A
rs12229892234553815781PTPN11umls:C0024623BeFreeWe observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC.0.0048100092013PTPN1112112485589GA
rs12229892234553815225PGCumls:C0024623BeFreeWe observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC.0.0098155152013PTPN1112112485589GA
rs122998425524923125ADH1Bumls:C0024623BeFreeNo association was observed between alcohol consumption, ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms and gastric cancer risk.0.0039956832015ADH1B499318162TC
rs122998422144473125ADH1Bumls:C0024623BeFreeA known functional SNP in ADH1B (rs1229984) was associated with alcohol intake (P-value = 0.04) but not GC risk.0.0039956832012ADH1B499318162TC
rs12537229715748897MTMR3umls:C0024623BeFreeOur study suggested that rs12537 is associated with susceptibility and prognosis of GC in southern Han Chinese, and miR-181a and its target gene MTMR3 play important roles in GC.0.0005428842012MTMR3;HORMAD2-AS12230027471CT
rs126028852342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013RPTOR1780545369GA
rs12683422252396441993ELAVL2umls:C0024623BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0008143262015LINGO2927969442CT
rs12917208177637517XRCC3umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0074484832010MGMT10129708019CT
rs12917208177634255MGMTumls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0067101022010MGMT10129708019CT
rs12917208177632067ERCC1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0104343432010MGMT10129708019CT
rs12917208177632068ERCC2umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0119111052010MGMT10129708019CT
rs12917208177634968OGG1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0125299332010MGMT10129708019CT
rs13181209815562068ERCC2umls:C0024623BeFreeERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis.0.0119111052011ERCC2;KLC31945351661TA,G
rs13275170230289001672DEFB1umls:C0024623BeFreeFour SNPS had no heterogeneity across the phases: in the meta-analysis, DEFA6 rs13275170 and DEFB1 rs2738169 had both a 1.3-fold increased odds ratio (OR) for gastric cancer (95% CIs = 1.1-1.6; and 1.1-1.5, respectively).0.0002714422012NA86922722TC
rs13275170230289001671DEFA6umls:C0024623BeFreeFour SNPS had no heterogeneity across the phases: in the meta-analysis, DEFA6 rs13275170 and DEFB1 rs2738169 had both a 1.3-fold increased odds ratio (OR) for gastric cancer (95% CIs = 1.1-1.6; and 1.1-1.5, respectively).0.0002714422012NA86922722TC
rs133617072203755126137ZBTB20umls:C0024623BeFreeWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.1205428842011PRKAA1540791782CT
rs13361707238612185734PTGER4umls:C0024623BeFreeA recent genome-wide association study (GWAS) identified new susceptibility single-nucleotide polymorphisms (SNPs) rs13361707 (PRKAA1 and PTGER4 gene on 5p13.1) and rs9841504 (ZBTB20 gene on 3q13.31) that were significantly associated with non-cardia gastric cancer.0.0005428842013PRKAA1540791782CT
rs13361707220375515734PTGER4umls:C0024623BeFreeWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.0005428842011PRKAA1540791782CT
rs13361707220375515562PRKAA1umls:C0024623BeFreeWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.1219000932011PRKAA1540791782CT
rs13361707220375515562PRKAA1umls:C0024623GWASCATWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.1219000932011PRKAA1540791782CT
rs13420827242895671788DNMT3Aumls:C0024623BeFreeThis study revealed that DNMT3a rs1550117 polymorphism is significantly associated with an increased risk of H. pylori infection, but did not support any evidence for contributions of DNMT3a rs1550117 and rs13420827 to either gastric atrophy or gastric cancer.0.0013572092015NA225231099CG
rs137854905244530343459IFNGR1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0002714422014IFNGR16137198270-ATTTCTGGAGTGATCACTCTCAGAACA
rs137854905244530342952GSTT1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0342565532014IFNGR16137198270-ATTTCTGGAGTGATCACTCTCAGAACA
rs137854905244530342950GSTP1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0214551782014IFNGR16137198270-ATTTCTGGAGTGATCACTCTCAGAACA
rs146806323042672983CDK1umls:C0024623BeFreeCDK1 rs4145643, FAS rs6586161, and FAS rs1468063 in the AKT signaling pathway presented significant genetic effects on gastric cancer (OR = 0.81 (95% CI: 0.66-0.99) for CDK1 rs4145643; OR = 1.27 (95% CI: 1.03-1.58) for FAS rs6586161; OR = 1.29 (95% CI: 1.03-1.56) for FAS rs1468063; Cochran Q statistics > 0.10).0.0005428842012FAS1089015534CT
rs1478604220111387057THBS1umls:C0024623BeFreePolymorphism of THBS1 rs1478604 A>G in 5-untranslated region is associated with lymph node metastasis of gastric cancer in a Southeast Chinese population.0.0032573022012THBS11539581120TC
rs148704956249654223605IL17Aumls:C0024623BeFreeThe present meta-analysis showed the IL- 17A G197A polymorphism is associated with a significantly increased risk for specific forms of cancer, especially in gastric cancer.0.0086101952014IL17A652187772AG
rs148704956250085673605IL17Aumls:C0024623BeFreeWe firstly show that the polymorphism of IL-17A G197A but not C1249T is a risk factor for gastric cancer.0.0086101952014IL17A652187772AG
rs1550117242895671788DNMT3Aumls:C0024623BeFreeThis study revealed that DNMT3a rs1550117 polymorphism is significantly associated with an increased risk of H. pylori infection, but did not support any evidence for contributions of DNMT3a rs1550117 and rs13420827 to either gastric atrophy or gastric cancer.0.0013572092015DNMT3A225343038AG
rs160277196551671462VCANumls:C0024623BeFreeGenetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer.0.0008143262010VCAN;LOC105379054583541812GT,A
rs1695244530343459IFNGR1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0002714422014GSTP11167585218AG
rs1695244530342950GSTP1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0214551782014GSTP11167585218AG
rs1695234567682950GSTP1umls:C0024623BeFreeThere were many studies investigating the association between GSTP1 gene Ile105Val polymorphism and gastric cancer risk, but studies from East Asians reported inconsistent findings.0.0214551782013GSTP11167585218AG
rs1695244530342952GSTT1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0342565532014GSTP11167585218AG
rs1799782253357377515XRCC1umls:C0024623BeFreeXRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.0.0176113842015XRCC11943553422GA
rs1799782191478607515XRCC1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0176113842009XRCC11943553422GA
rs179978219147860328APEX1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0024429772009XRCC11943553422GA
rs1799782229011837515XRCC1umls:C0024623BeFreeADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.0.0176113842012XRCC11943553422GA
rs1799782191478604968OGG1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0125299332009XRCC11943553422GA
rs179978222901183142PARP1umls:C0024623BeFreeADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.0.0027144192012XRCC11943553422GA
rs1799793255422284683NBNumls:C0024623BeFreeIn conclusion, our results suggest that ERCC1 rs11615, ERCC2 rs1799793, and NBN rs1805794 polymorphisms in the DNA repair pathways may influence the response to chemotherapy and OS of gastric cancer.0.0029099162014ERCC21945364001CT
rs1799793255422282067ERCC1umls:C0024623BeFreeBy the Cox analysis, the CC genotype of ERCC1 rs11615, AA genotype of ERCC2 rs1799793, and CC genotype of NBN rs1805794 were significantly associated with a longer overall survival (OS) of gastric cancer.0.0104343432014ERCC21945364001CT
rs1799793209815562068ERCC2umls:C0024623BeFreeERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis.0.0119111052011ERCC21945364001CT
rs1799793255422282068ERCC2umls:C0024623BeFreeIn conclusion, our results suggest that ERCC1 rs11615, ERCC2 rs1799793, and NBN rs1805794 polymorphisms in the DNA repair pathways may influence the response to chemotherapy and OS of gastric cancer.0.0119111052014ERCC21945364001CT
rs1799794213477867517XRCC3umls:C0024623BeFreeIn R0 resected patients, XRCC3 variants (rs861539, P = 0.04; rs861530, P = 0.02) in esophageal cancer, and XRCC3 (rs1799794, P = 0.02) and MTHFR (rs1801131, P = 0.005) in gastric cancer predicted survival.0.0074484832011XRCC314103712930TC
rs1800566247169851429CRYZumls:C0024623BeFreequinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and gastric cancer has been widely evaluated, but a definitive answer is so far lacking.0.0005428842014NQO11669711242GA
rs1800629241425277124TNFumls:C0024623BeFreeAssociation between tumor necrosis factor-α rs1800629 polymorphism and risk of gastric cancer: a meta-analysis.0.0338655592013TNF631575254GA
rs1800795238937093569IL6umls:C0024623BeFreeThe interleukin 6 -174 G/C (rs1800795) gene polymorphisms was analyzed in gastric cancer, peptic ulcer, and nonulcer dyspepsia patients and in healthy control subjects and the data were correlated with the histopathological features of the patients' biopsies.0.0134961492013IL6;LOC541472722727026CG
rs1801131213477867517XRCC3umls:C0024623BeFreeIn R0 resected patients, XRCC3 variants (rs861539, P = 0.04; rs861530, P = 0.02) in esophageal cancer, and XRCC3 (rs1799794, P = 0.02) and MTHFR (rs1801131, P = 0.005) in gastric cancer predicted survival.0.0074484832011MTHFR111794419TG
rs1801131213477864524MTHFRumls:C0024623BeFreeCox regression revealed ypT category (P = 0.001) and lymphatic vessel invasion (P = 0.03) to be independent prognostic factors for esophageal cancer, and histopathological response (P = 0.01), MTHFR variant (rs1801131, P = 0.002), and ypN category (P = 0.02) to be prognostic factors for gastric cancer.0.0364280882011MTHFR111794419TG
rs1801133253379024524MTHFRumls:C0024623BeFreeAfter shrinkage and adjusting for potential confounding factors, we found positive associations between MTHFR rs1801133 and stomach cancer (any T versus C/C, SB odds-ratio [SBOR]: 1.79, 95% posterior limits: 1.18, 2.71) and liver cancer (SBOR: 1.51, 95% posterior limits: 0.98, 2.32).0.0364280882014MTHFR111796321GA
rs1801200216497245743PTGS2umls:C0024623BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0369597022011NANANANANA
rs1801200216497243553IL1Bumls:C0024623BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0646693122011NANANANANA
rs1801201238445332064ERBB2umls:C0024623BeFreeAnalysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions.0.0701515552013ERBB21739723332AC,G
rs1801201238445331956EGFRumls:C0024623BeFreeOur data suggest that the EGFR-R521K and ERBB2-I655V polymorphisms are not suitable as markers for identifying individuals with a higher risk for developing gastric cancer in our population.0.030097712013ERBB21739723332AC,G
rs1801274217801943566IL4Rumls:C0024623BeFreeInterleukin-4 receptor (IL-4R) variant rs2107356 presented negative correlations to E-selectin variant rs5361 and FCGR2A variant rs1801274 (P = 0.035 and P = 0.023) in conferring susceptibility to gastric cancer.0.0029099162012FCGR2A1161509955AG
rs1801274217801942212FCGR2Aumls:C0024623BeFreeE-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.0.0026384742012FCGR2A1161509955AG
rs1801274217801946401SELEumls:C0024623BeFreeE-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.0.0019000932012FCGR2A1161509955AG
rs1801282183722845468PPARGumls:C0024623BeFreeWe investigated the association of Pro12Ala PPARgamma polymorphism and Helicobacter pylori infection with gastric cancer and peptic ulcer disease (PUD).0.0040716282008PPARG312351626CG
rs1801282177639505468PPARGumls:C0024623BeFreeOur study suggests that the PPARgamma Pro12Ala polymorphism may be a shared risk marker of both IFG and gastric cancer in Japanese.0.0040716282008PPARG312351626CG
rs1801282258247605468PPARGumls:C0024623BeFreePeroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.0.0040716282016PPARG312351626CG
rs1801394253379024552MTRRumls:C0024623BeFreeIn addition, we detected potential heterogeneity across alcohol drinking status for ORs relating MTRR rs1801394 to esophageal (posterior homogeneity P = 0.005) and stomach cancer (posterior homogeneity P = 0.004), and ORs relating MTR rs1805087 to liver cancer (posterior homogeneity P = 0.021).0.0031813582014MTRR;FASTKD357870860AG
rs1801394253379024548MTRumls:C0024623BeFreeIn addition, we detected potential heterogeneity across alcohol drinking status for ORs relating MTRR rs1801394 to esophageal (posterior homogeneity P = 0.005) and stomach cancer (posterior homogeneity P = 0.004), and ORs relating MTR rs1805087 to liver cancer (posterior homogeneity P = 0.021).0.0029099162014MTRR;FASTKD357870860AG
rs1803245253105236275S100A4umls:C0024623BeFreeThe S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.0.0038001862014S100A4;LOC1019280341153544766TA
rs1805087253379024548MTRumls:C0024623BeFreeIn addition, we detected potential heterogeneity across alcohol drinking status for ORs relating MTRR rs1801394 to esophageal (posterior homogeneity P = 0.005) and stomach cancer (posterior homogeneity P = 0.004), and ORs relating MTR rs1805087 to liver cancer (posterior homogeneity P = 0.021).0.0029099162014MTR1236885200AG
rs1805087253379024552MTRRumls:C0024623BeFreeIn addition, we detected potential heterogeneity across alcohol drinking status for ORs relating MTRR rs1801394 to esophageal (posterior homogeneity P = 0.005) and stomach cancer (posterior homogeneity P = 0.004), and ORs relating MTR rs1805087 to liver cancer (posterior homogeneity P = 0.021).0.0031813582014MTR1236885200AG
rs1805192258247605468PPARGumls:C0024623BeFreePeroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.0.0040716282016PPARG312379739CG
rs1805192177639505468PPARGumls:C0024623BeFreeOur study suggests that the PPARgamma Pro12Ala polymorphism may be a shared risk marker of both IFG and gastric cancer in Japanese.0.0040716282008PPARG312379739CG
rs1805192183722845468PPARGumls:C0024623BeFreeWe investigated the association of Pro12Ala PPARgamma polymorphism and Helicobacter pylori infection with gastric cancer and peptic ulcer disease (PUD).0.0040716282008PPARG312379739CG
rs1805794255422282067ERCC1umls:C0024623BeFreeBy the Cox analysis, the CC genotype of ERCC1 rs11615, AA genotype of ERCC2 rs1799793, and CC genotype of NBN rs1805794 were significantly associated with a longer overall survival (OS) of gastric cancer.0.0104343432014NBN889978251CG
rs1805794255422284683NBNumls:C0024623BeFreeIn conclusion, our results suggest that ERCC1 rs11615, ERCC2 rs1799793, and NBN rs1805794 polymorphisms in the DNA repair pathways may influence the response to chemotherapy and OS of gastric cancer.0.0029099162014NBN889978251CG
rs1805794255422282068ERCC2umls:C0024623BeFreeIn conclusion, our results suggest that ERCC1 rs11615, ERCC2 rs1799793, and NBN rs1805794 polymorphisms in the DNA repair pathways may influence the response to chemotherapy and OS of gastric cancer.0.0119111052014NBN889978251CG
rs18839652342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013MTOR111262099AG
rs191779924586594406881MIRLET7A1umls:C0024623BeFreeAn interaction effect of pri-let-7a-1 rs10739971 polymorphism with ERCC6 rs1917799 polymorphism was observed for the risk of gastric cancer (P interaction = 0.026); and interaction effects of pri-let-7a-1 rs10739971 polymorphism with PGC rs6458238 polymorphism (P interaction = 0.012) and PGC rs9471643 polymorphism (P interaction = 0.039) were observed for the risk of atrophic gastritis.0.0002714422014NA1049542929AC
rs1917799242896332074ERCC6umls:C0024623BeFreeThe DNA repair gene ERCC6 rs1917799 polymorphism is associated with gastric cancer risk in Chinese.0.0005428842014NA1049542929AC
rs2010963222926377422VEGFAumls:C0024623BeFreeVEGFA+936C/T and -634G/C polymorphisms and gastric cancer risk: a meta-analysis.0.0286209492011VEGFA643770613CG
rs2031920263730424193MDM2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0077958692015CYP2E110133526341CT
rs203192026373042328APEX1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0024429772015CYP2E110133526341CT
rs2031920263730421571CYP2E1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0193595872015CYP2E110133526341CT
rs2031920263730429360PPIGumls:C0024623BeFreeRisk analysis revealed that there was increased risk for gastric cancer in subjects with mutant alleles in APE 1 (rs2275008: OR 5.49, 95% CI = 2.6-5.7, p <.0001), NEIL 2 (rs804270: OR 2.3, 95% CI = 1.22-4.3, p=0.01), MDM2 (rs2279744: OR 14.65, 95% CI = 5.63-8.15, p < .0001), and CYP 2E1 (rs2031920: OR 8.385, 95% CI = 3.2-5.3, p < .0001) SNPs.0.0008143262015CYP2E110133526341CT
rs203192026373042252969NEIL2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0005428842015CYP2E110133526341CT
rs2071504223505055430POLR2Aumls:C0024623BeFreeOur findings provided evidence that the SNP rs2071504 in the exon of POLR2A gene would not only confer a decreased risk of gastric cancer, but also influence lymph node metastasis and TMN stage of gastric cancer in the Chinese population.0.0002714422012POLR2A177502618CT
rs2107356217801943566IL4Rumls:C0024623BeFreeInterleukin-4 receptor (IL-4R) variant rs2107356 presented negative correlations to E-selectin variant rs5361 and FCGR2A variant rs1801274 (P = 0.035 and P = 0.023) in conferring susceptibility to gastric cancer.0.0029099162012IL4R1627312083CT
rs213045179777161889ECE1umls:C0024623BeFreeOur results suggest that the ECE-1b C-338A polymorphism may be associated with increased risk of gastric cancer.0.0002714422008ECE1121290752GT
rs2227983238445331956EGFRumls:C0024623BeFreeOur data suggest that the EGFR-R521K and ERBB2-I655V polymorphisms are not suitable as markers for identifying individuals with a higher risk for developing gastric cancer in our population.0.030097712013EGFR755161562GA,C,T
rs2234922235801252052EPHX1umls:C0024623BeFreeAssociation of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India.0.0029099162013EPHX11225838705AG,T
rs22742232382624151196PLCE1umls:C0024623BeFreeIn this meta-analysis, the PLCE1 rs2274223 polymorphism was confirmed to have a statistically significant association with an increasing risk of ESCC and gastric cancer.0.1240716282013PLCE11094306584AG
rs2274223242543094582MUC1umls:C0024623BeFreeThe aim of this study was to determine whether rs4072037A > G in MUC1 at 1q22 and rs2274223A > G in PLCE1 at 10q23 are associated with a risk of gastric cancer in a Korean population.0.1295004662013PLCE11094306584AG
rs22742232425430951196PLCE1umls:C0024623BeFreeThe aim of this study was to determine whether rs4072037A > G in MUC1 at 1q22 and rs2274223A > G in PLCE1 at 10q23 are associated with a risk of gastric cancer in a Korean population.0.1240716282013PLCE11094306584AG
rs22742232379781551196PLCE1umls:C0024623BeFreeRecently, a single nucleotide polymorphism (rs2274223 A>G) in PLCE1 was reported as a novel susceptibility locus for esophageal and gastric cancers by genome-wide association studies performed in Chinese population.0.1240716282013PLCE11094306584AG
rs22742232072985251196PLCE1umls:C0024623BeFreeA notable signal was rs2274223, a nonsynonymous SNP located in PLCE1, for gastric cancer (P = 8.40 x 10(-9); per-allele odds ratio (OR) = 1.31) and ESCC (P = 3.85 x 10(-9); OR = 1.34).0.1240716282010PLCE11094306584AG
rs2275008263730421571CYP2E1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0193595872015OSGEP1420448090TC
rs2275008263730429360PPIGumls:C0024623BeFreeRisk analysis revealed that there was increased risk for gastric cancer in subjects with mutant alleles in APE 1 (rs2275008: OR 5.49, 95% CI = 2.6-5.7, p <.0001), NEIL 2 (rs804270: OR 2.3, 95% CI = 1.22-4.3, p=0.01), MDM2 (rs2279744: OR 14.65, 95% CI = 5.63-8.15, p < .0001), and CYP 2E1 (rs2031920: OR 8.385, 95% CI = 3.2-5.3, p < .0001) SNPs.0.0008143262015OSGEP1420448090TC
rs227500826373042252969NEIL2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0005428842015OSGEP1420448090TC
rs227500826373042328APEX1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0024429772015OSGEP1420448090TC
rs2275008263730424193MDM2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0077958692015OSGEP1420448090TC
rs2275913194140563605IL17Aumls:C0024623BeFreeWe concluded that G-197A polymorphism of IL-17A gene was significantly associated with the development of gastric cancer, especially intestinal-type cancer.0.0086101952009IL17A652186235GA
rs227633123431106999CDH1umls:C0024623BeFreeFour novel CDH1 sequence alterations were identified in GC patients including a G>T transition 49 bp before the start codon; a three-nucleotide deletion, c.44_46del TGC; one missense mutation, c.604G>A (V202I); and one variation in the intron, c.1320+7A>G. In addition, polymorphism frequencies were observed for CDH1-164delT, -161C>A, -73A>C, c.48+6C>T, c.48+62_48+63delinsCGTGCCCCAGCCC, c.894C>T (A298A), c.1224G>A (A408A), c.1888C>G (L630V), c.2076T>C (A692A), and c.2253C>T (N751N) which is similar to the data reported in http://www.ncbi.nlm.nih.gov/projects/SNP/.0.0551899152012CDH11668822177CG
rs22791152655416351196PLCE1umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.1240716282016BCL21863319604GT
rs2279115265541638000PSCAumls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0097719072016BCL21863319604GT
rs227911526554163596BCL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0152007452016BCL21863319604GT
rs227911526554163252969NEIL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0005428842016BCL21863319604GT
rs227974426373042252969NEIL2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0005428842015MDM21268808800TG
rs227974426373042328APEX1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0024429772015MDM21268808800TG
rs2279744263730421571CYP2E1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0193595872015MDM21268808800TG
rs2279744263730429360PPIGumls:C0024623BeFreeRisk analysis revealed that there was increased risk for gastric cancer in subjects with mutant alleles in APE 1 (rs2275008: OR 5.49, 95% CI = 2.6-5.7, p <.0001), NEIL 2 (rs804270: OR 2.3, 95% CI = 1.22-4.3, p=0.01), MDM2 (rs2279744: OR 14.65, 95% CI = 5.63-8.15, p < .0001), and CYP 2E1 (rs2031920: OR 8.385, 95% CI = 3.2-5.3, p < .0001) SNPs.0.0008143262015MDM21268808800TG
rs2279744234511114193MDM2umls:C0024623BeFreeMDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.0.0077958692013MDM21268808800TG
rs2279744263730424193MDM2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0077958692015MDM21268808800TG
rs229283224379078406938MIR146Aumls:C0024623BeFreeThe aim of the study was to investigated whether three common miRNA polymorphisms [miR-146a C>G (rs2910164), miR-149 T>C (rs2292832), and miR-196a2 T>C (rs11614913)] are associated with the susceptibility and prognosis of gastric cancer (GC) in the Greek population.0.0051573962013GPC1;MIR149;PP145712240456086TC
rs229283225795117406941MIR149umls:C0024623BeFreeIn summary, miR-27a rs895819 and miR-149 rs2292832 are of potential forewarning ability for gastric cancer risk.0.0010857672014GPC1;MIR149;PP145712240456086TC
rs229283224379078406941MIR149umls:C0024623BeFreeWe found that the risk for GC was significantly higher for the carriers of miR-149 rs2292832CC (p = 0.009) and miR-196a2 rs11614913CC (p < 0.0001) genotypes, as well as for the carriers of the rs2910164/rs2292832/rs11614913 CCC and GTC haplotype (p < 0.0001 and p = 0.03, respectively).0.0010857672013GPC1;MIR149;PP145712240456086TC
rs2294008255821628000PSCAumls:C0024623BeFreeThe PSCA rs2294008 C>T polymorphism may be acting through induction of gastric mucosal atrophy, finally leading to development of gastric ulcer and gastric cancer in PSCA rs2294008 T allele carriers, but not duodenal ulcer.0.0097719072015PSCA8142680513CT
rs22940082655416351196PLCE1umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.1240716282016PSCA8142680513CT
rs2294008240238158000PSCAumls:C0024623BeFreeWe analyzed 3 SNPs in the PSCA gene (rs2294008, rs9297976 and rs12155758) which were previously found to be associated with GC risk in Europeans.0.0097719072013PSCA8142680513CT
rs2294008200836438000PSCAumls:C0024623BeFreeRecently, two genome-wide association studies identified a significant association between the prostate stem cell antigen (PSCA) rs2294008 (C>T) polymorphism and risk of diffuse-type of gastric cancer in Asians and bladder cancer in Caucasians, respectively.0.0097719072010PSCA8142680513CT
rs2294008212681238000PSCAumls:C0024623BeFreePolymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese.0.0097719072011PSCA8142680513CT
rs2294008249621268000PSCAumls:C0024623BeFreeThe variant C allele of the reference SNP rs2294008 in the PSCA gene was associated with a significantly reduced risk of GC (per allele-adjusted odds ratio [aOR], 0.51; 95% confidence interval [CI], 0.33-0.77; P = .002).0.0097719072014PSCA8142680513CT
rs229400826554163596BCL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0152007452016PSCA8142680513CT
rs2294008265541638000PSCAumls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0097719072016PSCA8142680513CT
rs229400826554163252969NEIL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0005428842016PSCA8142680513CT
rs22940082215540584668FAM126Aumls:C0024623BeFreeThe results of subgroup analyses (according to histopathology, countries and sources of controls) indicated that T allele of rs2294008C>T and A allele rs2976392G>A were associated with increased risk of both intestinal- and diffuse-type GC, and associated with increased risk of GC for Chinese, Japanese, Koreans, PCC and HCC/PHCC.0.0016286512012PSCA8142680513CT
rs2294008229384758000PSCAumls:C0024623BeFreeAssociation of the PSCA rs2294008 C>T polymorphism with gastric cancer risk: evidence from a meta-analysis.0.0097719072012PSCA8142680513CT
rs2294008210707768000PSCAumls:C0024623BeFreeThe rs2294008 polymorphism in PSCA increases the risk of noncardia gastric cancer and its precursors in white individuals but protects against proximal cancers.0.0097719072011PSCA8142680513CT
rs2294008216817428000PSCAumls:C0024623BeFreeA genome-wide study performed in a Japanese population identified a strong association between SNP rs2294008 (Met1Thr) in the Prostate Stem Cell Antigen gene (PSCA) and diffuse-type gastric cancer (GC).0.0097719072012PSCA8142680513CT
rs2294008246546468000PSCAumls:C0024623BeFreeWe found that the T allele of rs2294008, an intronic variant of the PSCA gene at 8q24 that was previously associated with an increased risk of gastric cancer, was inversely associated with a decreased risk of ESCC (odds ratio = 0.90; 95% confidence interval, 0.81-0.99; P = 0.034).0.0097719072014PSCA8142680513CT
rs2294008223879988000PSCAumls:C0024623BeFreeThe C allele of rs2294008 at PSCA was associated with increased risk of duodenal ulcer (odds ratio (OR) = 1.84; P = 3.92 × 10(-33)) in a recessive model but was associated with decreased risk of gastric cancer (OR = 0.79; P = 6.79 × 10(-12)), as reported previously.0.0097719072012PSCA8142680513CT
rs2294008257217318000PSCAumls:C0024623BeFreeAssociation of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.0.0097719072015PSCA8142680513CT
rs2295080235558922475MTORumls:C0024623BeFreeA polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.0.0021715352013MTOR111262571GT
rs23017561958914252ACP1umls:C0024623BeFreeThis study aimed to examine the formerly reported association of G/A PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) polymorphism (rs2301756) with gastric atrophy, as well as the association with gastric cancer in a Japanese population using a large sample size.0.0019000932009PTPN1112112452972AG
rs243865216124074313MMP2umls:C0024623BeFreeEpistasis between PARP1 rs1136410 and MMP2 rs243865 increased the risk of LNM of GC.0.0134202042011MMP21655477894CT
rs25362342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013MTOR111106656TC
rs25487245902667515XRCC1umls:C0024623BeFreeResults from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.0.0176113842014XRCC11943551574TC
rs2548719147860328APEX1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0024429772009XRCC11943551574TC
rs25487191478607515XRCC1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0176113842009XRCC11943551574TC
rs25487155335917515XRCC1umls:C0024623BeFreeHowever, carrying at least one copy of the variant allele in XRCC1 Arg399Gln (codon 399 arganine to glutamine substitution) was associated with reduced risk of gastric cardia cancer (RR: 0.60, 95% CI: 0.37-0.97) and the combined category esophageal/gastric cancer (RR: 0.67, 95% CI: 0.48-0.95).0.0176113842004XRCC11943551574TC
rs25487232123247515XRCC1umls:C0024623BeFreeLack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.0.0176113842012XRCC11943551574TC
rs25487190349807515XRCC1umls:C0024623BeFreeXRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.0.0176113842008XRCC11943551574TC
rs25487191478604968OGG1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0125299332009XRCC11943551574TC
rs25489253357377515XRCC1umls:C0024623BeFreeXRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.0.0176113842015XRCC11943552260CT,G
rs256919024978812929CD14umls:C0024623BeFreeThis meta-analysis suggests that the CD14 -260C/T polymorphism may increase the risk of gastric cancer in H. pylori-infected individuals.0.0048100092014CD14;TMCO65140633331AG
rs2569190235652264695NDUFA2umls:C0024623BeFreeTLR4 rs11536889 and CD14 -260 C/T are associated with non-cardia GC in Chinese.0.0021715352013CD14;TMCO65140633331AG
rs268652342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013MLST8162203772AG
rs2738169230289001671DEFA6umls:C0024623BeFreeFour SNPS had no heterogeneity across the phases: in the meta-analysis, DEFA6 rs13275170 and DEFB1 rs2738169 had both a 1.3-fold increased odds ratio (OR) for gastric cancer (95% CIs = 1.1-1.6; and 1.1-1.5, respectively).0.0002714422012NA86885036GA
rs2738169230289001672DEFB1umls:C0024623BeFreeFour SNPS had no heterogeneity across the phases: in the meta-analysis, DEFA6 rs13275170 and DEFB1 rs2738169 had both a 1.3-fold increased odds ratio (OR) for gastric cancer (95% CIs = 1.1-1.6; and 1.1-1.5, respectively).0.0002714422012NA86885036GA
rs291016425202115574501MIR499Aumls:C0024623BeFreeWe evaluated the associations of three selected SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (hsa-mir-196a2, hsa-mir-146a and hsa-mir-499) with the prognosis of advanced gastric cancers (GCs) treated by chemotherapy.0.0010857672014LOC285628;MIR146A5160485411CG
rs291016424379078406938MIR146Aumls:C0024623BeFreeThe aim of the study was to investigated whether three common miRNA polymorphisms [miR-146a C>G (rs2910164), miR-149 T>C (rs2292832), and miR-196a2 T>C (rs11614913)] are associated with the susceptibility and prognosis of gastric cancer (GC) in the Greek population.0.0051573962013LOC285628;MIR146A5160485411CG
rs291016425455160406938MIR146Aumls:C0024623BeFreeThe association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis.0.0051573962014LOC285628;MIR146A5160485411CG
rs291016425386093406938MIR146Aumls:C0024623BeFreeMiR-146a rs2910164 polymorphism increases risk of gastric cancer: a meta-analysis.0.0051573962014LOC285628;MIR146A5160485411CG
rs291016425795117406938MIR146Aumls:C0024623BeFreeIn the stratified analysis, in some subgroup, heterozygous miR-146a rs2910164 was associated with a decreased risk of gastric cancer; and the variant genotype of miR-196a-2 rs11614913 was associated with an increased risk.0.0051573962014LOC285628;MIR146A5160485411CG
rs291016425326754406938MIR146Aumls:C0024623BeFreeMiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis.0.0051573962014LOC285628;MIR146A5160485411CG
rs291016424379078406941MIR149umls:C0024623BeFreeWe found that the risk for GC was significantly higher for the carriers of miR-149 rs2292832CC (p = 0.009) and miR-196a2 rs11614913CC (p < 0.0001) genotypes, as well as for the carriers of the rs2910164/rs2292832/rs11614913 CCC and GTC haplotype (p < 0.0001 and p = 0.03, respectively).0.0010857672013LOC285628;MIR146A5160485411CG
rs2910164207216257099TLR4umls:C0024623BeFreeThis study aimed to examine the associations of the miR-146a G/C (rs2910164) and TLR4 +3725 G/C (rs11536889) polymorphisms with the risk of Helicobacter pylori (H. pylori) infection, gastric atrophy, and gastric cancer in a Japanese population.0.0088816372011LOC285628;MIR146A5160485411CG
rs291016421073609406938MIR146Aumls:C0024623BeFreeThe rs2910164 (G>C) SNP in the miR-146a is associated with susceptibility to GC.0.0051573962010LOC285628;MIR146A5160485411CG
rs291016420721625406938MIR146Aumls:C0024623BeFreeThis study aimed to examine the associations of the miR-146a G/C (rs2910164) and TLR4 +3725 G/C (rs11536889) polymorphisms with the risk of Helicobacter pylori (H. pylori) infection, gastric atrophy, and gastric cancer in a Japanese population.0.0051573962011LOC285628;MIR146A5160485411CG
rs291016421073609574501MIR499Aumls:C0024623BeFreeWe evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population.0.0010857672010LOC285628;MIR146A5160485411CG
rs291016425202115406938MIR146Aumls:C0024623BeFreeWe evaluated the associations of three selected SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (hsa-mir-196a2, hsa-mir-146a and hsa-mir-499) with the prognosis of advanced gastric cancers (GCs) treated by chemotherapy.0.0051573962014LOC285628;MIR146A5160485411CG
rs29763922215540584668FAM126Aumls:C0024623BeFreeThe results of subgroup analyses (according to histopathology, countries and sources of controls) indicated that T allele of rs2294008C>T and A allele rs2976392G>A were associated with increased risk of both intestinal- and diffuse-type GC, and associated with increased risk of GC for Chinese, Japanese, Koreans, PCC and HCC/PHCC.0.0016286512012PSCA8142681514GA
rs3134613208742334610MYCLumls:C0024623BeFreeAssociation of a MYCL1 single nucleotide polymorphism, rs3134613, with susceptibility to diffuse-type gastric cancer and with differentiation of gastric cancer in a southeast Chinese population.0.007643982010MYCL;LOC105378668139899131CA
rs31602342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013MLST8;BRICD5162209190TC
rs3501027525474430406973MIR196A2umls:C0024623BeFreeEvaluation of a novel functional single-nucleotide polymorphism (rs35010275 G>C) in MIR196A2 promoter region as a risk factor of gastric cancer in a Chinese population.0.0031813582015MIR196A21253991008GC
rs351855239012342264FGFR4umls:C0024623BeFreeOur results suggest that the FGFR4 Gly388Arg polymorphism is not a risk factor for GC cancer initiation but that it is a useful prognostic marker for GC patients when the tumor is relatively small, well differentiated, or at an early clinical stage.0.0019000932013FGFR45177093242GA
rs36012910230539861788DNMT3Aumls:C0024623BeFreeDNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population.0.0013572092012NA225345310AG
rs3731239252396441993ELAVL2umls:C0024623BeFreeASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)).0.0008143262015CDKN2A921974219AG
rs374644425202115574501MIR499Aumls:C0024623BeFreeWe evaluated the associations of three selected SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (hsa-mir-196a2, hsa-mir-146a and hsa-mir-499) with the prognosis of advanced gastric cancers (GCs) treated by chemotherapy.0.0010857672014MYH7B;MIR499A;MIR499B2034990448AG
rs374644425202115406938MIR146Aumls:C0024623BeFreeWe evaluated the associations of three selected SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (hsa-mir-196a2, hsa-mir-146a and hsa-mir-499) with the prognosis of advanced gastric cancers (GCs) treated by chemotherapy.0.0051573962014MYH7B;MIR499A;MIR499B2034990448AG
rs374644421073609574501MIR499Aumls:C0024623BeFreeWe evaluated the associations of three SNPs (rs11614913, rs2910164, and rs3746444) in pre-miRNAs (miR-196a2, miR-146a, and miR-499) with the risk of gastric cancer (GC) and peptic ulcer diseases, and with the severity of Helicobacter pylori-induced gastritis in Japanese population.0.0010857672010MYH7B;MIR499A;MIR499B2034990448AG
rs374644424107911574501MIR499Aumls:C0024623BeFreeAssociation of the hsa-mir-499 (rs3746444) polymorphisms with gastric cancer risk in the Chinese population.0.0010857672014MYH7B;MIR499A;MIR499B2034990448AG
rs374644425795117574501MIR499Aumls:C0024623BeFreeNo association was found between miR-499 rs3746444 and gastric cancer risk.0.0010857672014MYH7B;MIR499A;MIR499B2034990448AG
rs37519322342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013RPTOR1780965614CT
rs37519342342373964223MLST8umls:C0024623BeFreeIn this study, we examined the associations between eight potential functional single nucleotide polymorphisms in the mTORC1 genes (rs2536T>C and rs1883965G>A for mTOR, rs3160T>C, and rs26865A>G for mLST8, rs3751934C>A, rs1062935T>C, rs3751932T>C, and rs12602885G>A for Raptor, not included in published gastric cancer genome-wide association studies) and gastric cancer risk in 1125 gastric cancer cases and 1196 cancer-free controls.0.0002714422013RPTOR1780964698CA
rs376040996208177632067ERCC1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0104343432010XPA997687210TC,G
rs376040996208177634968OGG1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0125299332010XPA997687210TC,G
rs376040996208177634255MGMTumls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0067101022010XPA997687210TC,G
rs376040996208177637517XRCC3umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0074484832010XPA997687210TC,G
rs376040996208177632068ERCC2umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0119111052010XPA997687210TC,G
rs3765524265541638000PSCAumls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0097719072016PLCE11094298541CT
rs37655242072985251196PLCE1umls:C0024623GWASCATA notable signal was rs2274223, a nonsynonymous SNP located in PLCE1, for gastric cancer (P = 8.40 x 10(-9); per-allele odds ratio (OR) = 1.31) and ESCC (P = 3.85 x 10(-9); OR = 1.34).0.1240716282010PLCE11094298541CT
rs37655242655416351196PLCE1umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.1240716282016PLCE11094298541CT
rs376552426554163252969NEIL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0005428842016PLCE11094298541CT
rs376552426554163596BCL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0152007452016PLCE11094298541CT
rs377566281253357377515XRCC1umls:C0024623BeFreeXRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.0.0176113842015XRCC11943552083CT
rs37812642072985251196PLCE1umls:C0024623GWASCATA notable signal was rs2274223, a nonsynonymous SNP located in PLCE1, for gastric cancer (P = 8.40 x 10(-9); per-allele odds ratio (OR) = 1.31) and ESCC (P = 3.85 x 10(-9); OR = 1.34).0.1240716282010PLCE11094310618AG
rs3789210255515875225PGCumls:C0024623BeFreeOur findings highlight an important role of PGC rs3789210 and rs6939861 in altering susceptibility to atrophic gastritis and/or gastric cancer.0.0098155152014PGC641743584CG
rs380798724065198857CAV1umls:C0024623BeFreeInteraction among Caveolin-1 genotypes (rs3807987/rs7804372), H. pylori infection, and risk of gastric cancer in a Chinese population.0.0027144192013CAV17116539780GA
rs386493716155335917515XRCC1umls:C0024623BeFreeHowever, carrying at least one copy of the variant allele in XRCC1 Arg399Gln (codon 399 arganine to glutamine substitution) was associated with reduced risk of gastric cardia cancer (RR: 0.60, 95% CI: 0.37-0.97) and the combined category esophageal/gastric cancer (RR: 0.67, 95% CI: 0.48-0.95).0.0176113842004NANANANANA
rs386493716245902667515XRCC1umls:C0024623BeFreeResults from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.0.0176113842014NANANANANA
rs386493716191478604968OGG1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0125299332009NANANANANA
rs386493716191478607515XRCC1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0176113842009NANANANANA
rs386493716232123247515XRCC1umls:C0024623BeFreeLack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.0.0176113842012NANANANANA
rs38649371619147860328APEX1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0024429772009NANANANANA
rs386493716190349807515XRCC1umls:C0024623BeFreeXRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.0.0176113842008NANANANANA
rs386526551208177632067ERCC1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0104343432010NANANANANA
rs386526551208177634968OGG1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0125299332010NANANANANA
rs386526551208177637517XRCC3umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0074484832010NANANANANA
rs386526551208177634255MGMTumls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0067101022010NANANANANA
rs386526551208177632068ERCC2umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0119111052010NANANANANA
rs386539567196551671462VCANumls:C0024623BeFreeGenetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer.0.0008143262010NANANANANA
rs386545546253357377515XRCC1umls:C0024623BeFreeXRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.0.0176113842015NANANANANA
rs38654554619147860328APEX1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0024429772009NANANANANA
rs386545546191478604968OGG1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0125299332009NANANANANA
rs386545546229011837515XRCC1umls:C0024623BeFreeADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.0.0176113842012NANANANANA
rs386545546191478607515XRCC1umls:C0024623BeFreeTo evaluate the association between genetic polymorphisms of X-ray repair cross-complementing group 1 (XRCC1, Arg194Trp and Arg399Gln), adenosine diphosphate ribosyl transferase (ADPRT, Val762Ala), 8-oxoguanine DNA glycosylase (OGG1, Ser326Cys) and apurinic/apyrimidinic endonuclease 1 (APE1, Asp148Glu) and evolution of H.pylori-associated precancerous gastric lesions, a population-based cohort study was conducted in Linqu County, a high-risk area of gastric cancer in China.0.0176113842009NANANANANA
rs38654554622901183142PARP1umls:C0024623BeFreeADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.0.0027144192012NANANANANA
rs3865472852377653754106TLR9umls:C0024623BeFreeFor TLR9 -1486 T/C, multiple logistic regression analyses revealed that compared with the TT homozygote, patients with both the TC variant (adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.04-2.10) and the CC variant (adjusted OR = 1.63, 95% CI = 1.01-2.64) had higher risks of gastric cancer.0.0008143262013NANANANANA
rs386596107202338536648SOD2umls:C0024623BeFreeTo investigate the association between MnSOD Val(16)Ala polymorphism and risk of advanced gastric lesions, and its effects on chemoprevention, a population-based study was conducted in Linqu, a high-risk area of gastric cancer in China.0.0037242412010NANANANANA
rs38660211824913346627BDNFumls:C0024623BeFreeThe aim of this study was to elucidate the association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and coping response to stress in patients diagnosed with advanced gastric cancer.0.0008143262014NANANANANA
rs386626619203061563717JAK2umls:C0024623BeFreeThe development of gastric cancer in a patient with polycythemia Vera, 3P deletion, and JAK2 V617F mutation.0.0024429772010NANANANANA
rs397507444168866084524MTHFRumls:C0024623BeFreeRecently, methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) mutations were discovered to be associated with childhood acute lymphoblastic leukemia (ALL), as well as colon cancer, lymphoma, esophageal and stomach cancer.0.0364280882006MTHFR111794407TG
rs397507444238975584524MTHFRumls:C0024623BeFreeThe polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.0.0364280882013MTHFR111794407TG
rs397507444204709424524MTHFRumls:C0024623BeFreeMethylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis.0.0364280882010MTHFR111794407TG
rs397507444251702324524MTHFRumls:C0024623BeFreeMethylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.0.0364280882014MTHFR111794407TG
rs397507444181624784524MTHFRumls:C0024623BeFreeMeta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.0.0364280882008MTHFR111794407TG
rs40239252037388731RNMTumls:C0024623BeFreeMET rs40239 may serve as a prognostic biomarker in locoregional gastric cancer.0.0084146982015MET7116677823GA
rs4072037247557684582MUC1umls:C0024623BeFreeIn conclusion, MUC1 rs4072037 polymorphism may be used as potential biomarker for cancer susceptibility particularly for gastric cancer and for Asian population.0.1295004662014MUC11155192276CT
rs4072037242543094582MUC1umls:C0024623BeFreeThe aim of this study was to determine whether rs4072037A > G in MUC1 at 1q22 and rs2274223A > G in PLCE1 at 10q23 are associated with a risk of gastric cancer in a Korean population.0.1295004662013MUC11155192276CT
rs4072037207298524582MUC1umls:C0024623GWASCATA shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.0.1295004662010MUC11155192276CT
rs40720372425430951196PLCE1umls:C0024623BeFreeThe aim of this study was to determine whether rs4072037A > G in MUC1 at 1q22 and rs2274223A > G in PLCE1 at 10q23 are associated with a risk of gastric cancer in a Korean population.0.1240716282013MUC11155192276CT
rs4072037240726534582MUC1umls:C0024623BeFreeFunctional polymorphism rs4072037 in MUC1 gene contributes to the susceptibility to gastric cancer: evidence from pooled 6,580 cases and 10,324 controls.0.1295004662013MUC11155192276CT
rs4072037228054904582MUC1umls:C0024623BeFreeThe rs4072037 polymorphism in MUC1 was associated with a reduced risk of GC of intestinal histological type (OR 0.4; 95% CI 0.2-0.9) and a reduced risk of oesophageal squamous cell cancer (OR 0.5; 95% CI 0.2-1.0), but not oesphageal adenocarcinoma.0.1295004662012MUC11155192276CT
rs4073235589933576CXCL8umls:C0024623BeFreeThe aim of this study was to investigate the association between the IL-8 (rs4073) -251A/T gene polymorphism and the risk of gastric cancer (GC).0.0443435092012CXCL8473740307AT
rs414564323042672983CDK1umls:C0024623BeFreeCDK1 rs4145643, FAS rs6586161, and FAS rs1468063 in the AKT signaling pathway presented significant genetic effects on gastric cancer (OR = 0.81 (95% CI: 0.66-0.99) for CDK1 rs4145643; OR = 1.27 (95% CI: 1.03-1.58) for FAS rs6586161; OR = 1.29 (95% CI: 1.03-1.56) for FAS rs1468063; Cochran Q statistics > 0.10).0.0005428842012NA1060803097GC
rs4635002216981582048EPHB2umls:C0024623BeFreeIn the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer.0.0070574892011DOCK110127064415AC
rs4635002216981581793DOCK1umls:C0024623BeFreeIn the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer.0.0002714422011DOCK110127064415AC
rs464761025002346836CASP3umls:C0024623BeFreeIn analysis of gene polymorphism of caspase3 intrinsic apoptotic pathway and gastric cancer susceptibility, polymorphism of CASP3 rs4647693, CASP3 rs12108497 and CASP3 rs4647610 increased gastric cancer risk (rs4647693: ORGA 1.61, 95 % CI 1.06-2.28; rs12108497: ORTC 1.55, 95 % CI 1.09-2.18; ORCC 2.45, 95 % CI 1.08-4.16; rs4647610: ORAG 1.71, 95 % CI 1.14-2.31; ORGG 1.60, 95 % CI 1.23-2.34).0.0070574892015CASP34184646777CT
rs464769325002346836CASP3umls:C0024623BeFreeIn analysis of gene polymorphism of caspase3 intrinsic apoptotic pathway and gastric cancer susceptibility, polymorphism of CASP3 rs4647693, CASP3 rs12108497 and CASP3 rs4647610 increased gastric cancer risk (rs4647693: ORGA 1.61, 95 % CI 1.06-2.28; rs12108497: ORTC 1.55, 95 % CI 1.09-2.18; ORCC 2.45, 95 % CI 1.08-4.16; rs4647610: ORAG 1.71, 95 % CI 1.14-2.31; ORGG 1.60, 95 % CI 1.23-2.34).0.0070574892015CASP34184629610TC
rs4648068227766194790NFKB1umls:C0024623BeFreeAssociation of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population.0.0092290242012NFKB14102597148AG
rs4711690234553815225PGCumls:C0024623BeFreeWe observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC.0.0098155152013PGC641741200CG
rs4711690234553815781PTPN11umls:C0024623BeFreeWe observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC.0.0048100092013PGC641741200CG
rs4880202338536648SOD2umls:C0024623BeFreeTo investigate the association between MnSOD Val(16)Ala polymorphism and risk of advanced gastric lesions, and its effects on chemoprevention, a population-based study was conducted in Linqu, a high-risk area of gastric cancer in China.0.0037242412010SOD26159692840AG
rs4938723256589807157TP53umls:C0024623BeFreeCombined analysis showed that subjects carrying the miR-34b/c rs4938723 CT/CC and TP53 CG/CC genotypes had a 0.62-fold decreased risk to develop gastric cancer compared with subjects carrying the miR-34b/c rs4938723 TT and TP53 CG/CC genotypes (OR=0.62; 95% CI, 0.40-0.96).0.0842778022015BTG4;MIR34B;MIR34C11111511840TC
rs4986790187556347099TLR4umls:C0024623BeFreeTLR4/D299G/T399I polymorphisms were more frequent in duodenal ulcer and showed a trend in gastric cancer, when compared with non-atrophic gastritis.0.0088816372008TLR49117713024AG
rs4986790174620923576CXCL8umls:C0024623BeFreeAssessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer.0.0443435092007TLR49117713024AG
rs498679019847953929CD14umls:C0024623BeFreeOur data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.0.0048100092007TLR49117713024AG
rs4986790174620927099TLR4umls:C0024623BeFreeAssessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer.0.0088816372007TLR49117713024AG
rs4986790198479534695NDUFA2umls:C0024623BeFreeOur data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.0.0021715352007TLR49117713024AG
rs4986790198479537099TLR4umls:C0024623BeFreeOur data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.0.0088816372007TLR49117713024AG
rs4986790240075387099TLR4umls:C0024623BeFreeThe results of this meta-analysis indicate that the TLR4 Asp299Gly and Thr399Ile polymorphisms are risk factors for gastric cancer development.0.0088816372014TLR49117713024AG
rs4986790235652267099TLR4umls:C0024623BeFreeBased on our meta-analysis, the TLR signalling pathway is involved in gastric carcinogenesis, TLR4 Asp299Gly and TLR2 -196 to -174del showing associations with GC in an ethnic-specific manner.0.0088816372013TLR49117713024AG
rs4986790193262137099TLR4umls:C0024623BeFreeWe investigated the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile, and CD14 promoter-C159T on the risk of gastric cancer including its subtypes and clinicopathologic features.0.0088816372009TLR49117713024AG
rs4986790188264957099TLR4umls:C0024623BeFreeToll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes.0.0088816372008TLR49117713024AG
rs4986790235652267097TLR2umls:C0024623BeFreeBased on our meta-analysis, the TLR signalling pathway is involved in gastric carcinogenesis, TLR4 Asp299Gly and TLR2 -196 to -174del showing associations with GC in an ethnic-specific manner.0.0019000932013TLR49117713024AG
rs4986790240075387097TLR2umls:C0024623BeFreeThe association between Toll-like receptor 2 (TLR2) -196 to -174del polymorphism and Toll-like receptor 4 (TLR4) polymorphisms (Asp299Gly, Thr399Ile, and 3725G>C) and gastric cancer risk are still conflicting.0.0019000932014TLR49117713024AG
rs4986791240075387099TLR4umls:C0024623BeFreeThe results of this meta-analysis indicate that the TLR4 Asp299Gly and Thr399Ile polymorphisms are risk factors for gastric cancer development.0.0088816372014TLR49117713324CT
rs4986791174620927099TLR4umls:C0024623BeFreeAssessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer.0.0088816372007TLR49117713324CT
rs4986791198479534695NDUFA2umls:C0024623BeFreeOur data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.0.0021715352007TLR49117713324CT
rs4986791198479537099TLR4umls:C0024623BeFreeOur data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.0.0088816372007TLR49117713324CT
rs4986791187556347099TLR4umls:C0024623BeFreeTLR4/D299G/T399I polymorphisms were more frequent in duodenal ulcer and showed a trend in gastric cancer, when compared with non-atrophic gastritis.0.0088816372008TLR49117713324CT
rs498679119847953929CD14umls:C0024623BeFreeOur data suggest that CD14 promoter-159TT and T carrier were associated with lower risk of developing gastric mucosal atrophy in H. pylori infected patients more than 61 years of age, and these genotypes may reduce the risk of intestinal type gastric cancer and TLR4 Asp299Gly, Thr399Ile are very rare in the Japanese population.0.0048100092007TLR49117713324CT
rs4986791188264957099TLR4umls:C0024623BeFreeToll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes.0.0088816372008TLR49117713324CT
rs4986791174620923576CXCL8umls:C0024623BeFreeAssessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer.0.0443435092007TLR49117713324CT
rs4986791240075387097TLR2umls:C0024623BeFreeThe association between Toll-like receptor 2 (TLR2) -196 to -174del polymorphism and Toll-like receptor 4 (TLR4) polymorphisms (Asp299Gly, Thr399Ile, and 3725G>C) and gastric cancer risk are still conflicting.0.0019000932014TLR49117713324CT
rs4986791193262137099TLR4umls:C0024623BeFreeWe investigated the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile, and CD14 promoter-C159T on the risk of gastric cancer including its subtypes and clinicopathologic features.0.0088816372009TLR49117713324CT
rs5275223852565743PTGS2umls:C0024623BeFreeOur findings indicate that PTGS2 rs5275T/C may be a candidate genetic marker for gastric cancer susceptibility.0.0369597022012PTGS21186673926AG
rs5361217801946401SELEumls:C0024623BeFreeE-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.0.0019000932012SELE1169731919TG
rs5361217801942212FCGR2Aumls:C0024623BeFreeE-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.0.0026384742012SELE1169731919TG
rs5361217801943566IL4Rumls:C0024623BeFreeInterleukin-4 receptor (IL-4R) variant rs2107356 presented negative correlations to E-selectin variant rs5361 and FCGR2A variant rs1801274 (P = 0.035 and P = 0.023) in conferring susceptibility to gastric cancer.0.0029099162012SELE1169731919TG
rs5743618230671427096TLR1umls:C0024623BeFreeThe TLR1 I602S SNP is significantly associated with GC (p = .002) and gastric ulcer (p = .051).0.0005428842013TLR1438797027CA
rs5744174219944057100TLR5umls:C0024623BeFreeThese findings suggest that TLR2 c. -196 to -174 ins > del, TLR5 rs5744174 and interaction between rs5744174 and H. pylori infection were associated with the development of GC.0.0005428842011TLR51223111186AG
rs5999749216981581793DOCK1umls:C0024623BeFreeIn the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer.0.0002714422011MAPK12221833371AC
rs5999749216981582048EPHB2umls:C0024623BeFreeIn the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer.0.0070574892011MAPK12221833371AC
rs62936724760009406882MIRLET7A2umls:C0024623BeFreepri-let-7a-2 rs629367 CC genotype could increase the risks of gastric cancer as well as atrophic gastritis and was also associated with poor survival of gastric cancer, which possibly by affecting the mature let-7a expression, and could serve as a predicting biomarker for high-risk and poor prognosis of gastric cancer.0.0002714422014MIR100HG;MIRLET7A211122146306CA
rs63750114221364354292MLH1umls:C0024623BeFreeThe MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males.0.0246688732011MLH1337049015CA,T
rs63750447201777934292MLH1umls:C0024623BeFreeA new familial gastric cancer-related gene polymorphism: T1151A in the mismatch repair gene hMLH1.0.0246688732011MLH1337025749TA
rs645823824586594406881MIRLET7A1umls:C0024623BeFreeAn interaction effect of pri-let-7a-1 rs10739971 polymorphism with ERCC6 rs1917799 polymorphism was observed for the risk of gastric cancer (P interaction = 0.026); and interaction effects of pri-let-7a-1 rs10739971 polymorphism with PGC rs6458238 polymorphism (P interaction = 0.012) and PGC rs9471643 polymorphism (P interaction = 0.039) were observed for the risk of atrophic gastritis.0.0002714422014NA641749967GA
rs6458238234553815781PTPN11umls:C0024623BeFreeWe observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC.0.0048100092013NA641749967GA
rs6458238234553815225PGCumls:C0024623BeFreeWe observed that PGC rs6458238, PGC rs4711690 and PTPN11 rs12229892 were associated with susceptibilities to GA and/or GC.0.0098155152013NA641749967GA
rs658616123042672983CDK1umls:C0024623BeFreeCDK1 rs4145643, FAS rs6586161, and FAS rs1468063 in the AKT signaling pathway presented significant genetic effects on gastric cancer (OR = 0.81 (95% CI: 0.66-0.99) for CDK1 rs4145643; OR = 1.27 (95% CI: 1.03-1.58) for FAS rs6586161; OR = 1.29 (95% CI: 1.03-1.56) for FAS rs1468063; Cochran Q statistics > 0.10).0.0005428842012ACTA2;FAS1088981502TA
rs667242019728008864RUNX3umls:C0024623BeFreeOur study results revealed that the RUNX3 intronic T/A polymorphism (rs760805) might modulate the risk of gastric atrophy among H. pylori seropositive subjects, and the RUNX3 T/A polymorphism at exon 1 (rs6672420) had little influence on the risks of H. pylori infection, gastric atrophy or gastric cancer in Japanese people.0.0181866052009RUNX3;LOC105376878124964519AT
rs67125524923125ADH1Bumls:C0024623BeFreeNo association was observed between alcohol consumption, ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms and gastric cancer risk.0.0039956832015ALDH212111803962GA
rs67123455379217ALDH2umls:C0024623BeFreeThe aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer.0.008534252013ALDH212111803962GA
rs689466216497243553IL1Bumls:C0024623BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0646693122011PTGS2;PACERR1186681619TC
rs689466216497245743PTGS2umls:C0024623BeFreeIn the Chinese subgroup, nominally significant associations were shown between (i) EBBR2+1963G (rs1801200) and H. pylori infection (per-allele OR: 0.48, 95% CI 0.23, 0.98, P = 0.04), (ii) PTGS2-1195G (rs689466) and an increased risk of GC on adjusting for H. pylori status (OR: 1.53, 95% CI 0.99, 2.37, P = 0.05), and (iii) IL1B-1473C (rs1143623) and a decreased risk of GC (OR: 0.64, 95% CI 0.41, 0.99, P = 0.05).0.0369597022011PTGS2;PACERR1186681619TC
rs6939861255515875225PGCumls:C0024623BeFreeOur findings highlight an important role of PGC rs3789210 and rs6939861 in altering susceptibility to atrophic gastritis and/or gastric cancer.0.0098155152014TFEB641735303GA
rs69825524923125ADH1Bumls:C0024623BeFreeNo association was observed between alcohol consumption, ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms and gastric cancer risk.0.0039956832015ADH1C499339632TC,A
rs712237292753845KRASumls:C0024623BeFreeA let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.0.0138871432013KRAS1225209618AC
rs7121200276782778GNASumls:C0024623BeFreeAssociation of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer.0.0026384742009GNAS2058903752CT
rs71748309244530343459IFNGR1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0002714422014NANANANANA
rs71748309244530342950GSTP1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0214551782014NANANANANA
rs71748309244530342952GSTT1umls:C0024623BeFreeAssociation study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.0.0342565532014NANANANANA
rs7270882551039910666CD226umls:C0024623BeFreeCD226 rs727088A>G polymorphism increases the susceptibility to gastric cancer in Chinese populations.0.0002714422014CD2261869863203GA
rs7387222072985211200CHEK2umls:C0024623GWASCATA shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.0.1213572092010CHEK22228734024TC
rs744166248642516774STAT3umls:C0024623BeFreers744166 polymorphism of the STAT3 gene is associated with risk of gastric cancer in a Chinese population.0.0105862332014STAT31742362183AG
rs744839262496539758508KMT2Cumls:C0024623BeFreeA missense mutation (S3660L) in MLL3 gene influences risk of gastric cancer.0.0013572092014KMT2C7152162598GA
rs7528484215237701385CREB1umls:C0024623BeFreeThe risk-associated, minor variant of an intestinal-type gastric cancer-associated SNP in the RUNX3 distal promoter (rs7528484) significantly increased promoter activity in a CREB1-dependent manner.0.0010857672011RUNX3124966177CT
rs76080519728008864RUNX3umls:C0024623BeFreeOur study results revealed that the RUNX3 intronic T/A polymorphism (rs760805) might modulate the risk of gastric atrophy among H. pylori seropositive subjects, and the RUNX3 T/A polymorphism at exon 1 (rs6672420) had little influence on the risks of H. pylori infection, gastric atrophy or gastric cancer in Japanese people.0.0181866052009RUNX3124925432AT
rs76080523959374864RUNX3umls:C0024623BeFreeRunt-related transcription factor 3: single nucleotide polymorphism rs760805, gene expression, and methylation status in Helicobacter pylori -infected patients for determination of gastric cancer risk.0.0181866052014RUNX3124925432AT
rs763780253389883605IL17Aumls:C0024623BeFreeOur meta analysis reveal the IL-17A rs763780T>C gene polymorphism is involved in risk of gastric cancer but not other tumor types.0.0086101952015IL17F;LOC105375088652236941TC
rs76378025147431112744IL17Fumls:C0024623BeFreeThe IL-17F rs763780T>C polymorphism was also significantly associated with gastric cancer development.0.0039956832014IL17F;LOC105375088652236941TC
rs77375493203061563717JAK2umls:C0024623BeFreeThe development of gastric cancer in a patient with polycythemia Vera, 3P deletion, and JAK2 V617F mutation.0.0024429772010JAK2;INSL695073770GA,T
rs780437224065198857CAV1umls:C0024623BeFreeInteraction among Caveolin-1 genotypes (rs3807987/rs7804372), H. pylori infection, and risk of gastric cancer in a Chinese population.0.0027144192013CAV17116554174TA
rs7853122216981582048EPHB2umls:C0024623BeFreeIn the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer.0.0070574892011RAPGEF19131705224CT
rs7853122216981581793DOCK1umls:C0024623BeFreeIn the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer.0.0002714422011RAPGEF19131705224CT
rs79991725266802672BRCA1umls:C0024623BeFreeThe functional BRCA1 rs799917 genetic polymorphism is associated with gastric cancer risk in a Chinese Han population.0.0035287442014BRCA11743092919GT,C,A
rs804270263730424193MDM2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0077958692015NEIL2811770112GC
rs804270265541638000PSCAumls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0097719072016NEIL2811770112GC
rs8042702655416351196PLCE1umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.1240716282016NEIL2811770112GC
rs804270263730421571CYP2E1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0193595872015NEIL2811770112GC
rs80427026554163252969NEIL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0005428842016NEIL2811770112GC
rs80427026554163596BCL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0152007452016NEIL2811770112GC
rs80427026373042252969NEIL2umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0005428842015NEIL2811770112GC
rs80427026373042328APEX1umls:C0024623BeFreeIn conclusion, variant alleles in the NEIL2 (rs804270), APE1 (rs2275008), CYP2E1 (rs2031920) and MDM2 (rs2279744) SNPs may independently influence susceptibility to gastric cancer in a Northern Jiangsu Chinese population.0.0024429772015NEIL2811770112GC
rs804270263730429360PPIGumls:C0024623BeFreeRisk analysis revealed that there was increased risk for gastric cancer in subjects with mutant alleles in APE 1 (rs2275008: OR 5.49, 95% CI = 2.6-5.7, p <.0001), NEIL 2 (rs804270: OR 2.3, 95% CI = 1.22-4.3, p=0.01), MDM2 (rs2279744: OR 14.65, 95% CI = 5.63-8.15, p < .0001), and CYP 2E1 (rs2031920: OR 8.385, 95% CI = 3.2-5.3, p < .0001) SNPs.0.0008143262015NEIL2811770112GC
rs812623724109406960MIR184umls:C0024623BeFreeThe miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.0.0002714422013TNFAIP2;LOC10537068414103137232CT
rs8126237241097127TNFAIP2umls:C0024623BeFreeThe miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.0.0002714422013TNFAIP2;LOC10537068414103137232CT
rs850624595048732253TDRG1umls:C0024623BeFreeThe has-miR-526b binding-site rs8506G>a polymorphism in the lincRNA-NR_024015 exon identified by GWASs predispose to non-cardia gastric cancer risk.0.0002714422014TDRG1640379813CT
rs861530213477867517XRCC3umls:C0024623BeFreeIn R0 resected patients, XRCC3 variants (rs861539, P = 0.04; rs861530, P = 0.02) in esophageal cancer, and XRCC3 (rs1799794, P = 0.02) and MTHFR (rs1801131, P = 0.005) in gastric cancer predicted survival.0.0074484832011XRCC314103707786TC
rs861539208177637517XRCC3umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0074484832010KLC1;XRCC314103699416GA
rs861539208177634968OGG1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0125299332010KLC1;XRCC314103699416GA
rs861539208177632067ERCC1umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0104343432010KLC1;XRCC314103699416GA
rs861539213477867517XRCC3umls:C0024623BeFreeIn R0 resected patients, XRCC3 variants (rs861539, P = 0.04; rs861530, P = 0.02) in esophageal cancer, and XRCC3 (rs1799794, P = 0.02) and MTHFR (rs1801131, P = 0.005) in gastric cancer predicted survival.0.0074484832011KLC1;XRCC314103699416GA
rs861539243150147517XRCC3umls:C0024623BeFreeXRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.0.0074484832013KLC1;XRCC314103699416GA
rs861539208177634255MGMTumls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0067101022010KLC1;XRCC314103699416GA
rs861539208177632068ERCC2umls:C0024623BeFreePolymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), nucleotide excision repair (XPC-PAT, XPA-23G>A, ERCC1-19007T>C and XPD-L751Q), recombination (XRCC3-T241M) and alkylation damage reversal (MGMT-L84F) were tested for their potential role in the development of GC by using logistic regression models.0.0119111052010KLC1;XRCC314103699416GA
rs861539150191597517XRCC3umls:C0024623BeFreePolymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population.0.0074484832004KLC1;XRCC314103699416GA
rs861539259730837517XRCC3umls:C0024623BeFreeAssociation of XRCC3 gene rs861539 polymorphism with gastric cancer risk: evidence from a case-control study and a meta-analysis.0.0074484832014KLC1;XRCC314103699416GA
rs861539205495767517XRCC3umls:C0024623BeFreeRelationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.0.0074484832011KLC1;XRCC314103699416GA
rs861539241979747517XRCC3umls:C0024623BeFreeQuantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.0.0074484832013KLC1;XRCC314103699416GA
rs89581925795117406941MIR149umls:C0024623BeFreeIn summary, miR-27a rs895819 and miR-149 rs2292832 are of potential forewarning ability for gastric cancer risk.0.0010857672014LOC284454;MIR23A;MIR24-2;MIR27A1913836478TA,C,G
rs8958192066677865986ZBTB10umls:C0024623BeFreeIn conclusion, we were the first to show that a common polymorphism (rs895819) in hsa-mir-27a, by modulating miR-27a and ZBTB10 levels, acted as an important factor of the gastric cancer susceptibility.0.0002714422010LOC284454;MIR23A;MIR24-2;MIR27A1913836478TA,C,G
rs90925326554163252969NEIL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0005428842016LTA;LOC100287329631572536AG
rs9092532655416351196PLCE1umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.1240716282016LTA;LOC100287329631572536AG
rs909253265541638000PSCAumls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0097719072016LTA;LOC100287329631572536AG
rs90925326554163596BCL2umls:C0024623BeFreeGenetic Variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) Genes and Their Correlation to Gastric Cancer Risk Based on Universal Tagged Arrays and Fe3O4 Magnetic Nanoparticles.0.0152007452016LTA;LOC100287329631572536AG
rs909253227488504049LTAumls:C0024623BeFreeA functional polymorphism of lymphotoxin-alpha (LTA) gene rs909253 is associated with gastric cancer risk in an Asian population.0.0090011892012LTA;LOC100287329631572536AG
rs9297976240238158000PSCAumls:C0024623BeFreeWe analyzed 3 SNPs in the PSCA gene (rs2294008, rs9297976 and rs12155758) which were previously found to be associated with GC risk in Europeans.0.0097719072013PSCA;JRK8142670817TC
rs947164324586594406881MIRLET7A1umls:C0024623BeFreeAn interaction effect of pri-let-7a-1 rs10739971 polymorphism with ERCC6 rs1917799 polymorphism was observed for the risk of gastric cancer (P interaction = 0.026); and interaction effects of pri-let-7a-1 rs10739971 polymorphism with PGC rs6458238 polymorphism (P interaction = 0.012) and PGC rs9471643 polymorphism (P interaction = 0.039) were observed for the risk of atrophic gastritis.0.0002714422014NA641751177GC
rs9841504220375515562PRKAA1umls:C0024623BeFreeWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.1219000932011ZBTB203114643917CG
rs98415042203755126137ZBTB20umls:C0024623BeFreeWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.1205428842011ZBTB203114643917CG
rs9841504220375515734PTGER4umls:C0024623BeFreeWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.0005428842011ZBTB203114643917CG
rs9841504238612185734PTGER4umls:C0024623BeFreeA recent genome-wide association study (GWAS) identified new susceptibility single-nucleotide polymorphisms (SNPs) rs13361707 (PRKAA1 and PTGER4 gene on 5p13.1) and rs9841504 (ZBTB20 gene on 3q13.31) that were significantly associated with non-cardia gastric cancer.0.0005428842013ZBTB203114643917CG
rs98415042203755126137ZBTB20umls:C0024623GWASCATWe identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).0.1205428842011ZBTB203114643917CG
rs990434121161671332BIRC5umls:C0024623BeFreeThe present result suggests that the presence of the C allele of -31C/G Survivin promoter polymorphism in combination with D17S250 instability may be used as a risk factor for gastric cancer in our population.0.0048859542011BIRC51778214286GC
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:24)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
1155157715rs2070803AGrs2070803184880301.20E-06Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
1155182164rs2075570CTrs2075570184880309.20E-07Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
3101306507rs3804775CTrs3804775184880302.40E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
3101371899rs2303474GTrs2303474184880305.40E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
3114362764rs9841504CGrs9841504220375512.00E-09NA1.32[1.20-1.45] 1,006 Chinese ancestry cases; 2,273 Chinese ancestry controlsChinese(3279)ALL(3279)ASN(3279)ALL(3279)Gastric cancerHPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaD013274Stomach NeoplasmsEFOID:0000178gastric carcinomaGastrointestinal cancerGastrointestinal tumorNAResearch Support, Non-U.S. Gov'tC
540791884rs13361707CTrs13361707220375518.00E-29NA1.41[1.32-1.49]1,006 Chinese ancestry cases; 2,273 Chinese ancestry controlsChinese(3279)ALL(3279)ASN(3279)ALL(3279)Gastric cancerHPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaD013274Stomach NeoplasmsEFOID:0000178gastric carcinomaGastrointestinal cancerGastrointestinal tumorNAResearch Support, Non-U.S. Gov'tC
8143759137rs2978981CTrs2978981184880304.00E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143759364rs2976387GArs2976387184880301.20E-10Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143761172rs13262164CTrs13262164184880301.50E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143761931rs2294008CTrs2294008184880301.50E-17Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143761931rs2294008CTrs2294008184880305.10E-04Intestinal-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143762430rs2294010AGrs2294010184880305.10E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143762724rs2976391CArs2976391184880301.70E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143762932rs2976392GArs2976392184880305.00E-04Intestinal-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143762932rs2976392GArs2976392184880306.40E-18Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143763043rs2920298AGrs2920298184880305.00E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143763547rs1045531CArs1045531184880304.80E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143763622rs2976394CTrs2976394184880303.50E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143763690rs10216533GArs10216533184880303.60E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143763750rs2976395GArs2976395184880303.90E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143764001rs2976396GArs2976396184880304.90E-09Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143782044rs2585174AGrs2585174184880302.20E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
8143784500rs2244163TGrs2244163184880302.90E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
94602398rs301451CGrs301451184880302.50E-04Diffuse-type gastric cancerNANA188 Japanese cases; 752 Japanese controlsJapanese(940)ALL(940)ASN(940)ALL(940)Gastric cancer (diffuse-type gastric cancer)HPOID:0012126Stomach cancerDOID:3717gastric adenocarcinomaNANANANAGastrointestinal cancerGastrointestinal tumorNAMulticenter StudyResearch Support, Non-U.S. Gov't
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)